学术周报 · IF≥10 或专科旗舰刊
急重症领域文献阅读汇编
2026年第47周 (2026-11-20) | PubMed (NLM) · DeepSeek 中英双语
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
数据来源: PubMed E-utilities · 影响因子筛选: IF≥10 或专科旗舰刊 · 完整摘要不截断
★本周 Top 10 高影响力文献
Ŧ期刊分布统计
| 期刊 | 篇数 | IF |
|---|---|---|
| Critical care medicine | 10 | IF 7.5 |
| Chest | 4 | IF 9.8 |
| Circulation | 2 | IF 41.3 |
| Cellular & molecular immunology | 1 | IF 23.9 |
| Physiological reviews | 1 | IF 35.7 |
| Journal of the American Chemical Society | 1 | IF 16.6 |
| Nature structural & molecular biology | 1 | IF 10.1 |
| Kidney international | 1 | IF 21.8 |
| EBioMedicine | 1 | IF 11.2 |
| JAMA surgery | 1 | IF 15.6 |
1循环支持与休克 (7篇)
临床研究 (5篇)
Clinically important upper gastrointestinal bleeding may increase mortality and time to discharge from the ICU. Conventional analyses ignore timing and treat bleeding as a binary event. We evaluated the association between time-dependent clinically important upper gastrointestinal bleeding and ICU mortality. A multicenter cohort study using data from an international stress ulcer prophylaxis trial. A total of 4821 invasively ventilated adult participants. None. A multistate model was specified with two transient ICU states (bleed-free and post-bleed) and four absorbing states (ICU discharge or death, each with or without bleeding). The Aalen-Johansen method was used to estimate transition and state occupancy probabilities and to describe risks of different clinical courses. Follow-up was censored at 90 days. We fit two Cox models for time to death in the ICU regressing on time-dependent bleeding history while adjusting for age, sex, baseline Acute Physiology and Chronic Health Evaluation II score, admission category (medical/surgical/trauma), vasopressor/inotrope use and renal replacement therapy on study day 1 and randomized allocation of pantoprazole or placebo; a second model also adjusted for time-dependent covariates of advanced life support (invasive mechanical ventilation, vasopressor/inotrope use, and renal replacement therapy). Clinically important upper gastrointestinal bleeding developed in 104 patients (2.2%) in the ICU. Median ICU length of stay for those who experienced bleeding was 19 days (interquartile range [IQR], 11-30 d) vs. 9 days (IQR, 5-15 d) for those who did not. Accounting for immortal time bias, the time-dependent indicator of clinically important upper gastrointestinal bleeding was associated with increased ICU mortality (hazard ratio, 1.56; 95% CI, 1.13-2.15). At any time, patients who experienced bleeding had approximately 1.6 times the hazard of ICU mortality compared with those without a history of bleeding. Clinically important upper gastrointestinal bleeding as a time-dependent event is associated with an increased risk of ICU mortality.
中文摘要:临床上重要的上消化道出血可能增加死亡率并延长ICU住院时间。传统分析往往忽略时间因素并将出血视为二元事件。本研究评估了时间依赖性临床上重要的上消化道出血与ICU死亡率之间的关联。这是一项多中心队列研究,数据来源于一项国际应激性溃疡预防试验。研究对象为4821名接受有创通气的成年参与者。研究未设置对照组。我们构建了一个包含两个瞬态ICU状态(无出血和出血后)和四个吸收状态(出院或死亡,每种状态均分为有出血和无出血)的多状态模型。采用Aalen-Johansen方法估计转移概率和状态占据概率,以描述不同临床病程的风险。随访在90天时截尾。我们拟合了两个Cox模型,用于分析ICU内死亡时间对时间依赖性出血史的回归关系,并调整了年龄、性别、基线急性生理与慢性健康评估II评分、入院类别(内科/外科/创伤)、研究第1天的血管活性药物或正性肌力药物使用及肾脏替代治疗情况,以及泮托拉唑或安慰剂的随机分配;第二个模型还进一步调整了高级生命支持的时间依赖性协变量(有创机械通气、血管活性药物或正性肌力药物使用及肾脏替代治疗)。在ICU中,104名患者(2.2%)发生了临床上重要的上消化道出血。发生出血患者的中位ICU住院时间为19天(四分位距为11-30天),而未发生出血者为9天(四分位距为5-15天)。在考虑了 immortal time bias 后,临床上重要的上消化道出血的时间依赖性指标与ICU死亡率增加相关(风险比为1.56;95%置信区间为1.13-2.15)。在任何时间点,经历过出血的患者其ICU死亡风险约为无出血史患者的1.6倍。作为时间依赖性事件的临床上重要的上消化道出血与ICU死亡率增加的风险相关。
The role of guideline-directed medical therapy (GDMT) in patients with cardiogenic shock (CS) supported by mechanical circulatory support remains poorly defined. The feasibility and potential benefits of early GDMT initiation during Impella support are uncertain. We analyzed a multicenter prospective registry of consecutive patients with CS treated with Impella between 2020 and 2024. GDMT exposure was defined as the number of heart failure therapies administered at device explantation. The primary outcome was in-hospital mortality. Multivariable logistic regression adjusted for clinical severity and early shock trajectory. Landmark analysis excluded patients dying within 5 days, while mixed-effects models accounted for center-level clustering. Among 140 patients (mean age 61 years; 20% female), 40% received concomitant ECMO (ECPella). In-hospital mortality was 38%. At explantation, 43% received at least one GDMT agent. Greater GDMT exposure was independently associated with lower mortality (OR 0.28 per additional therapy; 95% CI 0.14-0.58; p<0.001). This association remained consistent in landmark analysis (adjusted OR 0.31; 95% CI 0.16-0.66; p<0.001) and after excluding patients with cardiac arrest (adjusted OR 0.48; 95% CI 0.23-0.88; p=0.002). A graded relationship between GDMT intensity and survival was observed. Center-level variability was negligible (intraclass correlation coefficient 0.02). In patients with CS supported by Impella, early GDMT implementation was feasible in a substantial proportion of patients. Greater GDMT exposure at device explantation was associated with lower in-hospital mortality. Ventricular unloading may provide an opportunity to initiate outcome-modifying therapies during the acute phase of CS.
中文摘要:在机械循环支持下的心源性休克患者中,指南指导的药物治疗的作用尚不明确。早期启动GDMT的可行性和潜在益处仍不确定。我们分析了2020年至2024年间接受Impella治疗的心源性休克连续患者的多中心前瞻性登记数据。GDMT暴露定义为拔除装置时给予的心衰治疗数量。主要结局为院内死亡率。多变量逻辑回归调整了临床严重程度和早期休克轨迹。地标分析排除了5天内死亡的患者,混合效应模型考虑了中心水平的聚类。在140名患者中(平均年龄61岁;20%为女性),40%接受了ECMO联合治疗。院内死亡率为38%。拔除装置时,43%的患者接受了至少一种GDMT药物。更高的GDMT暴露量与较低的死亡率独立相关(每增加一项治疗OR 0.28;95%CI 0.14-0.58;p<0.001)。这种关联在地标分析中保持一致(调整OR 0.31;95%CI 0.16-0.66;p<0.001),并在排除心脏骤停患者后依然成立(调整OR 0.48;95%CI 0.23-0.88;p=0.002)。观察到GDMT强度与生存率之间存在剂量反应关系。中心水平的变异可忽略不计(组内相关系数0.02)。在Impella支持的心源性休克患者中,早期实施GDMT在相当比例的患者中是可行的。拔除装置时更高的GDMT暴露量与较低的院内死亡率相关。心室卸载可能为在心源性休克急性期启动改善预后的治疗提供机会。
People with peripheral artery disease (PAD) are often misdiagnosed or diagnosed late and, even after diagnosis, are undertreated with both pharmacologic and invasive therapies. The disease is associated with an increased risk of mortality, myocardial infarction, stroke, other vascular disease, limb loss, and reduced quality of life. Although the risks and long-term management of PAD are well documented, these risks are acutely magnified when PAD exists as a comorbidity in patients hospitalized for other cardiovascular or medical conditions. Procedures requiring vascular access for the treatment of acute myocardial infarction, cardiogenic shock, or valvular heart disease, as well as procedures for the treatment of the patient's underlying PAD, require special consideration in patients with PAD. Familiarity with the use and placement of mechanical circulatory support in patients with PAD, as well as the management of recent endovascular or surgical vascular interventions, is essential for providing appropriate care in the acute care setting.
中文摘要:外周动脉疾病患者常被误诊或诊断延迟,即使确诊后,在药物和介入治疗方面也存在治疗不足的问题。该疾病与死亡率增加、心肌梗死、卒中、其他血管疾病、肢体丧失及生活质量下降的风险相关。尽管外周动脉疾病的长期风险和管理已有充分记录,但当其作为合并症存在于因其他心血管或内科疾病住院的患者中时,这些风险会急剧放大。为急性心肌梗死、心源性休克或瓣膜性心脏病治疗而需进行血管通路的手术,以及针对患者基础外周动脉疾病的治疗手术,均需在患有外周动脉疾病的患者中进行特别考量。熟悉机械循环支持在外周动脉疾病患者中的使用与放置,以及近期血管内或外科血管干预的管理,对于在急性医疗环境中提供适当护理至关重要。
Right ventricular failure (RVF) is a high-mortality form of cardiogenic shock frequently encountered in critical illness and is often underrecognized due to its heterogeneous presentation. This article presents a physiology-driven, stepwise approach to the diagnosis and management of acute RVF using a longitudinal case in the intensive care unit. We highlight practical bedside tools for recognition, including point-of-care ultrasound and invasive hemodynamics, and review targeted strategies for preload optimization, afterload reduction, and contractility support. Special emphasis is placed on airway management, vasoactive medications, and timely escalation to mechanical circulatory support (MCS) in appropriately selected patients. This bedside "How I Do It" guide is written for intensivists and pulmonary/critical care clinicians and translates advanced hemodynamic and device concepts into practical decision points for acute care management.
中文摘要:右心衰竭(RVF)是危重疾病中常见的高死亡率心源性休克形式,常因其表现异质性而被忽视。本文通过重症监护室中的纵向病例,展示了一种基于生理学的急性右心衰竭诊断与管理步骤式方法。我们强调了包括床旁超声和侵入性血流动力学在内的实用床旁识别工具,并回顾了针对前负荷优化、后负荷降低和心肌收缩力支持的靶向策略。特别强调气道管理、血管活性药物以及在适当选择的患者中及时升级至机械循环支持(MCS)。这份面向重症医师及肺病/重症监护临床医生的「How I Do It」指南,将先进的血流动力学和设备概念转化为急性护理管理的实用决策点。
To reconstruct venous return physiology across published studies of septic shock and characterize the distribution of circulatory states represented in the literature. Exploratory physiologic reconstruction study. Secondary analysis of published hemodynamic observations. Adult patients with septic shock reported in studies containing sufficient information for reconstruction of mean circulatory filling pressure analogue (Pmca) and related parameters including venous return driving pressure (VRdP) and resistance to venous return (RVR). None. A total of 150 observations were available. Median Pmca, central venous pressure (CVP), VRdP, and RVR were 17.3 mm Hg, 9.0 mm Hg, 7.9 mm Hg, and 1.04 mm Hg/min/L, respectively. Empirical quartiles identified four recurrent circulatory phenotypes: reduced filling pressure/gradient, preserved venous return, elevated venous pressure, and high-resistance venous return. The preserved venous return pattern demonstrated the highest median cardiac output (CO), whereas the high-resistance pattern exhibited the lowest flow despite comparable filling pressures. In exploratory adjusted analyses incorporating available vasopressor exposure and fluid-therapy context, VRdP remained strongly associated with CO (β, 1.03 L/min/mm Hg; 95% CI, 0.80-1.25; p < 0.001). When Pmca and CVP were entered separately, Pmca was positively associated with CO (β, 1.02; 95% CI, 0.79-1.25; p < 0.001), whereas CVP was inversely associated with CO (β, -1.03; 95% CI, -1.26 to -0.80; p < 0.001). Published hemodynamic observations in septic shock occupy distinct Guytonian phenotypes characterized by different combinations of circulatory filling pressure, venous pressure, and RVR. Reconstruction of venous return geometry may provide a physiologic framework for interpreting circulatory heterogeneity in septic shock.
中文摘要:目的:重建脓毒症休克中静脉回流生理学特征,并表征文献中代表的循环状态分布。设计:探索性生理重建研究。数据源:对包含足够信息以重建平均循环充盈压类似物(Pmca)及相关参数(包括静脉回流驱动压VRdP和静脉回流阻力RVR)的已发表血流动力学观察数据进行二次分析。对象:报道了成人脓毒症休克患者的研究,且包含上述重建所需信息。干预措施:无。结果:共获得150个观测数据。中位Pmca、中心静脉压(CVP)、VRdP和RVR分别为17.3 mmHg、9.0 mmHg、7.9 mmHg和1.04 mmHg/min/L。经验四分位数确定了四种复发的循环表型:充盈压/梯度降低、静脉回流保留、静脉压升高和高阻力静脉回流。保留的静脉回流模式表现出最高的中位心输出量(CO),而高阻力模式在填充压相当的情况下表现出最低的流量。在纳入可用血管加压药暴露和液体治疗背景的探索性调整分析中,VRdP与CO仍强相关(β=1.03 L/min/mmHg;95% CI, 0.80-1.25;p < 0.001)。当分别输入Pmca和CVP时,Pmca与CO呈正相关(β=1.02;95% CI, 0.79-1.25;p < 0.001),而CVP与CO呈负相关(β=-1.03;95% CI, -1.26至-0.80;p < 0.001)。结论:已发表的脓毒症休克血流动力学观察结果占据不同的Guytonian表型,其特征为循环充盈压、静脉压和RVR的不同组合。重建静脉回流几何结构可能为解释脓毒症休克的循环异质性提供生理学框架。
基础研究 (2篇)
The choice of vasopressor during Caesarean delivery to prevent maternal hypotension remains debated. This study aimed to determine the concentration-dependent effects of vasopressors on pregnant myometrium, with and without oxytocin. In this prospective ex vivo study, myometrial samples were obtained from full-term pregnant women during elective Caesarean delivery. Myometrial contractility to vasopressors was recorded in the absence/presence of oxytocin compared with controls. Concentration-response testing was done with ephedrine, phenylephrine, and norepinephrine. The primary outcome was the motility index (amplitude×frequency). Isolated primary myometrial cells were also used for calcium mobilisation assays. Myometrial samples were obtained from 32 females. The mean motility index increased with ephedrine (+39.9%; 95% CI 20.6-62.5; P<0.001) and phenylephrine (+36.2%; 95% CI 19.3-55.4; P<0.001), but norepinephrine had no effect (+12.0%; 95% CI -0.7 to 26.1; P=0.066) compared with control. Similar changes in motility index were observed in the presence of oxytocin. Calcium mobilisation recordings on primary myometrial cells supported the contractility findings, with increases in intracellular calcium ions after ephedrine and phenylephrine, but not with norepinephrine compared with control. Ephedrine and phenylephrine increased ex vivo human myometrial contractility, both independently and in combination with oxytocin, consistent with improving uterine tone during Caesarean delivery. Norepinephrine does not affect myometrial contractility, suggesting that it is safe to use before delivery.
中文摘要:剖宫产术中预防产妇低血压的血管收缩剂选择仍存在争议。本研究旨在确定血管收缩剂对妊娠子宫肌层浓度依赖性的影响,以及加用缩宫素后的变化。这是一项前瞻性离体研究,在择期剖宫产期间从足月孕妇获取子宫肌样本。记录有无缩宫素存在时子宫肌对血管收缩剂的收缩反应并与对照组比较。采用麻黄碱、去氧肾上腺素和去甲肾上腺素进行浓度-反应测试。主要结局指标为运动指数(振幅乘以频率)。分离的原代子宫肌细胞也用于钙动员测定。共从32名女性获取子宫肌样本。与对照组相比,麻黄碱(+39.9%;95% CI 20.6-62.5;P<0.001)和去氧肾上腺素(+36.2%;95% CI 19.3-55.4;P<0.001)使平均运动指数增加,而去甲肾上腺素无显著影响(+12.0%;95% CI -0.7 to 26.1;P=0.066)。在存在缩宫素的情况下观察到类似的运动指数变化。原代子宫肌细胞的钙动员记录支持了收缩性研究结果,麻黄碱和去氧肾上腺素导致细胞内钙离子增加,而去甲肾上腺素则无此效应。麻黄碱和去氧肾上腺素在离体条件下增加了人子宫肌的收缩力,无论单独使用还是与缩宫素联合使用,均有助于改善剖宫产术中的子宫张力。去甲肾上腺素不影响子宫肌收缩力,提示其在分娩前使用是安全的。
The combination of severe burns with delayed fluid resuscitation (B+DR) can lead to excessive oxidative stress and a highly inflammatory hepatic microenvironment, ultimately contributing to acute liver injury. Although nanosystems with multiple enzyme-mimicking activities show promise for scavenging reactive oxygen species (ROS) and providing hepatic protection, their inherent mechanical stiffness and limited active migration severely restrict their diffusion and penetration into tissues, resulting in unsatisfactory therapeutic efficacy. In this study, soft movable nanosystems (SMNs) were developed by integrating pre-synthesized ultrasmall Fe-Cur nanoparticles and the mitochondrial targeting peptide elamipretide (SS-31) into the surface and internal cavities of soft thioether-bridged mesoporous organosilica nanocapsules. The soft and ultrathin framework of SMNs conferred markedly enhanced active migratory behavior compared with their conventional stiff counterparts. These SMNs also exhibited efficient intracellular ROS clearance, alleviated mitochondrial damage, and reduced the release of mitochondrial DNA (mtDNA) and inflammatory cytokines from hepatocytes, collectively suppressing inflammatory signaling and inhibiting pro-inflammatory M1 polarization in liver macrophages. Furthermore, the structural softness of the SMNs facilitated improved hepatic accumulation, leading to significantly enhanced therapeutic outcomes in B+DR-induced liver injury.
中文摘要:严重烧伤联合延迟液体复苏(B+DR)可导致过度氧化应激和高炎症性肝微环境,最终导致急性肝损伤。尽管具有多种酶模拟活性的纳米系统在清除活性氧(ROS)和提供肝脏保护方面显示出前景,但其固有的机械刚性和有限的主动迁移能力严重限制了其在组织中的扩散和渗透,导致治疗效果不理想。在本研究中,通过将预合成的超小Fe-Cur纳米颗粒和线粒体靶向肽elamipretide(SS-31)整合到软硫醚桥接介孔有机硅纳米胶囊的表面和内腔中,开发了软可移动纳米系统(SMNs)。与传统刚性对应物相比,SMNs的柔软超薄框架赋予了显著增强的主动迁移行为。这些SMN还表现出高效的细胞内ROS清除能力,减轻了线粒体损伤,并减少了肝细胞中线粒体DNA(mtDNA)和炎症因子的释放,共同抑制炎症信号传导并抑制肝脏巨噬细胞的促炎M1极化。此外,SMNs的结构柔软性促进了肝脏积累能力的提高,从而在B+DR诱导的肝损伤中显著增强了治疗效果。
2ARDS与呼吸支持 (6篇)
临床研究 (5篇)
The use of veno-venous extracorporeal life support (VV-ECLS) for severe acute respiratory distress syndrome (ARDS) has increased substantially worldwide. However, approaches to liberation from extracorporeal support remain poorly defined, with no standardized protocols or validated readiness criteria. What are the global practices for VV-ECLS liberation among Extracorporeal Life Support Organization (ELSO) centers? Where is there variability in readiness assessment, liberation strategies, and use of standardized protocols? We formulated a cross-sectional survey of 25 questions regarding liberation practices among ECLS providers. Questions focused on assessed parameters for readiness to liberate, determination of liberation success, and strategies to optimize it. Surveys were distributed electronically to 765 institutions globally registered with ELSO between July 1st and Aug 15th, 2022. Descriptive statistics were used to summarize responses. Of 765 centers contacted, 340 (44%) responded, with 209 (61%) reporting use of VV-ECLS. Most centers were adult-focused, intensivist-led programs with moderate annual volumes. Most respondents (58%) prioritized VV-ECLS liberation before liberation from mechanical ventilation. Readiness for liberation was most determined by improvement in oxygenation under lung-protective ventilation (92%) and respiratory system compliance (90%), while fewer centers used inspiratory effort indices (34%). Liberation strategies were heterogeneous, with progressive reduction of sweep gas flow being most common (40%). Liberation trial duration varied widely (median 120 minutes; mean 497 ± 635 minutes), and most centers performed one trial per day. Arterial blood gas abnormalities (90%) and clinical signs of respiratory distress were the primary indicators of liberation failure. Only 42% of centers reported using a formal liberation protocol. VV-ECLS liberation practices vary substantially across centers and are largely guided by institutional experience rather than standardized evidence. These findings highlight the need for validated physiologic predictors and protocolized strategies to optimize safe and timely liberation from VV-ECLS.
中文摘要:静脉-静脉体外生命支持(VV-ECLS)在重症急性呼吸窘迫综合征(ARDS)中的应用在全球范围内显著增加。然而,脱离体外支持的策略仍定义不清,缺乏标准化方案或经过验证的 readiness 标准。本研究旨在探讨 ELSO 中心关于 VV-ECLS 脱离的全球实践及在评估准备状态、脱离策略和标准化方案使用方面的差异。我们制定了针对 ECLS 提供者脱离实践的 25 项横断面调查,问题聚焦于评估脱离准备状态的参数、确定脱离成功的方法以及优化策略。2022 年 7 月 1 日至 8 月 15 日期间,通过电子方式向全球注册的 765 家 ELSO 机构分发问卷。使用描述性统计汇总回复结果。在联系的 765 个中心中,340 个(44%)进行了回复,其中 209 个(61%)报告使用 VV-ECLS。大多数中心为以成人为主的、由重症医师主导的项目,年病例量中等。大多数受访者(58%)优先考虑在脱离机械通气之前进行 VV-ECLS 脱离。脱离准备状态主要根据肺保护性通气下的氧合改善(92%)和呼吸系统顺应性(90%)来确定,而较少中心使用吸气努力指数(34%)。脱离策略异质性大,其中逐步减少扫气流量最为常见(40%)。脱离试验持续时间差异很大(中位数 120 分钟;平均 497 ± 635 分钟),大多数中心每天进行一次试验。动脉血气异常(90%)和呼吸窘迫的临床体征是脱离失败的主要指标。仅 42% 的中心报告使用正式的脱离方案。VV-ECLS 脱离实践在各中心间差异显著,主要受机构经验而非标准化证据指导。这些发现凸显了验证生理预测因子和制定方案化策略以优化安全及时脱离 VV-ECLS 的需求。
To evaluate the efficacy of high-flow nasal cannula (HFNC) compared with conventional oxygen therapy (COT) in adults with de novo acute hypoxemic respiratory failure (AHRF) using a meta-analysis with trial sequential analysis (TSA). MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched from database inception to April 7, 2026. Randomized controlled trials (RCTs) comparing HFNC with COT in adults with de novo AHRF. Two investigators independently performed study selection, data extraction, risk-of-bias assessment, and certainty assessment, with discrepancies resolved through discussion. A total of 13 RCTs involving 4294 patients were included in the analysis. Compared with COT, HFNC was associated with a lower risk of intubation (Risk ratio [RR], 0.88; 95% CI, 0.78-0.99; low certainty), but not mortality (RR, 0.96; 95% CI, 0.83-1.10; moderate certainty). TSA indicated that the cumulative evidence was insufficient to establish a conclusive effect for either outcome. Although HFNC was associated with a statistically significant reduction in hospital length of stay (mean difference, -0.84 d; 95% CI, -1.26 to -0.43; low certainty), the clinical importance of this reduction remains uncertain. No significant differences were observed in escalation of therapy (RR, 0.87; 95% CI, 0.75-1.01; very low certainty), ICU admission (RR, 0.84; 95% CI, 0.50-1.39; very low certainty), or ICU length of stay (mean difference, -0.10 d; 95% CI, -0.82 to 0.61; very low certainty). In adults with de novo AHRF, HFNC may reduce the need for endotracheal intubation but probably does not improve survival compared with COT.
中文摘要:目的:通过荟萃分析与试验序贯分析(TSA)评估高流量鼻导管氧疗(HFNC)与传统氧疗(COT)在成人新发急性低氧性呼吸衰竭(AHRF)中的疗效。方法:检索MEDLINE、Embase及Cochrane对照试验注册库,纳入比较HFNC与COT治疗成人新发AHRF的随机对照试验(RCTs),检索时间截至2026年4月7日。两名研究者独立进行文献筛选、数据提取、偏倚风险评估及证据质量评估,分歧通过讨论解决。结果:共纳入13项RCT,涉及4294名患者。与COT相比,HFNC降低气管插管风险(风险比[RR] 0.88;95%置信区间[CI] 0.78-0.99;低质量证据),但未降低死亡率(RR 0.96;95% CI 0.83-1.10;中等质量证据)。TSA显示累积证据不足以确立任一结局的确定性效应。HFNC显著缩短住院时间(均数差 -0.84天;95% CI -1.26至-0.43;低质量证据),但其临床意义尚不确定。在升级治疗(RR 0.87;95% CI 0.75-1.01;极低质量证据)、ICU入院率(RR 0.84;95% CI 0.50-1.39;极低质量证据)或ICU住院时间(均数差 -0.10天;95% CI -0.82至0.61;极低质量证据)方面未见显著差异。结论:在成人新发AHRF患者中,HFNC可能减少气管插管需求,但可能未改善生存率。
Although chest radiographs (CXR) are among the most used imaging modalities in critically ill patients, their interpretation and clinical significance remain incompletely leveraged. The Radiographic Lung Edema (RALE) score is a prognostic bedside tool widely applied in adults to quantify lung edema on CXR. However, this score has been infrequently studied in children, and its potential to reflect broader aspects of critical illness pathophysiology beyond the lungs is unknown. We sought to determine the reproducibility of the RALE score, and whether higher RALE scores were associated with circulating inflammatory and endothelial biomarkers, multi-organ dysfunction, and worse clinical outcomes in pediatric acute respiratory failure (ARF). Retrospective cohort study. Multicenter PICUs. Critically ill children (2 wk to 17 yr old) receiving invasive mechanical ventilation (IMV) for ARF, enrolled in the CAF-PINT (Coagulation and Fibrinolysis in Pediatric Insulin Titration) study (2012-2016). None. A baseline RALE score was calculated for each patient from a single CXR obtained within 72 hours of IMV initiation. Among 212 patients, RALE scores demonstrated good inter-rater reliability (intra-class coefficient 0.85; 95% CI, 0.82-0.87). After adjustment for ARF etiology and illness severity, higher RALE scores were associated with fewer 28-day ventilator-free days (sub-distribution hazard ratio per 1-sd increase, 0.81; 95% CI, 0.69-0.95). Structural equation modeling demonstrated that this association was mediated through both pulmonary dysfunction, measured by the oxygenation index (β -0.14; 95% bootstrapped CI, -0.22 to -0.06), and extrapulmonary organ dysfunction, measured by the Pediatric Logistic Organ Dysfunction score (β -0.05; 95% bootstrapped CI, -0.10 to -0.002). Similar associations were observed for 28-day PICU-free days. Finally, penalized regression selected soluble triggering receptor expressed on myeloid cells-1, intercellular adhesion molecule-1, and tumor necrosis factor receptor-1 as biomarkers associated with higher RALE scores. We provide evidence that the RALE score is not solely a lung injury marker but also reflects broader systemic pathophysiology. These findings have important implications for the interpretation and clinical application of this bedside tool in pediatric ARF.
中文摘要:尽管胸部X线片是危重患者最常用的影像学检查手段,但其解读和临床意义尚未得到充分利用。放射学肺水肿评分是一种在成人中广泛应用的预后床旁工具,用于量化胸部X线片上的肺水肿情况。然而,该评分在儿童中的应用研究较少,且其反映超出肺部范围的危重病病理生理其他方面的潜力尚不明确。本研究旨在确定放射学肺水肿评分的可重复性,并探讨较高的评分是否与儿科急性呼吸衰竭患儿的循环炎症和内皮生物标志物、多器官功能障碍及不良临床结局相关。这是一项回顾性队列研究,在多中心儿科重症监护室进行。研究对象为2周至17岁因急性呼吸衰竭接受有创机械通气的危重儿童,这些患儿来自CAF-PINT研究(2012-2016年)。研究对每位患者在开始有创机械通气后72小时内获取的单张胸部X线片计算基线放射学肺水肿评分。在212名患者中,放射学肺水肿评分显示出良好的组间可靠性(组内相关系数0.85;95%置信区间0.82-0.87)。在调整急性呼吸衰竭病因和疾病严重程度后,较高的放射学肺水肿评分与较少的28天无呼吸机天数相关(每增加一个标准差的亚分布风险比为0.81;95%置信区间0.69-0.95)。结构方程模型显示,这种关联通过肺部功能障碍(以氧合指数衡量)和肺外器官功能障碍(以儿科逻辑器官功能障碍评分衡量)介导。28天无重症监护室天数也观察到类似的关联。最后,惩罚性回归选择可溶性髓系细胞触发受体-1、细胞间黏附分子-1和肿瘤坏死因子受体-1作为与较高放射学肺水肿评分相关的生物标志物。我们提供的证据表明,放射学肺水肿评分不仅是肺损伤的标志物,还反映了更广泛的系统性病理生理过程。这些发现对该床旁工具在儿科急性呼吸衰竭中的解读和临床应用具有重要意义。
Frailty is associated with worse outcomes after coronary artery bypass grafting (CABG). However, the comparative effectiveness of off-pump CABG (OPCAB) versus on-pump CABG (ONCAB) in prefrail and frail patients remains uncertain. This multicenter, randomized, open-label trial enrolled patients ≥60 years of age classified as prefrail or frail, randomized 1:1, between January 2018 and December 2024. The primary outcome was a 30-day composite of death, myocardial infarction, stroke, renal failure, acute respiratory distress syndrome, or reoperation for bleeding. Secondary outcomes included ventilation time, intensive care unit and hospital stay, transfusion requirements, completeness of revascularization, surgical wound infection at 30 days, and neurocognitive function preoperatively and at 1 year. Analyses followed the intention-to-treat principle; relative risks with 95% CIs were estimated. A total of 508 patients were included (OPCAB, n=258; ONCAB, n=250; median age, 68 years [interquartile range, 65.0-73]; 30.5% female). The primary composite outcome occurred in 28 patients receiving OPCAB (10.9%) and 40 patients receiving ONCAB (16.0%; relative risk, 1.47 [95% CI, 0.94-2.31]; P=0.09). Surgical wound infection was more frequent with ONCAB (20 [8.0%] versus 9 [3.5%]; P=0.04). No significant differences were observed in neurocognitive or quality of life outcomes at 1 year. Estimated 1-year survival probabilities were 96.1% and 92.8% in the OPCAB and ONCAB groups, respectively (P=0.099). In prefrail and frail patients undergoing CABG, OPCAB and ONCAB resulted in similar rates of the primary composite outcome. No significant differences between OPCAB and ONCAB were found in neurocognitive outcomes. URL: https://www.clinicaltrials.gov; Unique identifier: NCT02338947.
中文摘要:衰弱与冠状动脉旁路移植术(CABG)后不良预后相关。然而,非体外循环CABG(OPCAB)与体外循环CABG(ONCAB)在预衰弱及衰弱患者中的比较疗效尚不明确。本研究是一项多中心随机开放标签试验,于2018年1月至2024年12月期间招募年龄≥60岁且被分类为预衰弱或衰弱的患者,按1:1比例随机分组。主要终点为30天内死亡、心肌梗死、卒中、肾衰竭、急性呼吸窘迫综合征或因出血再次手术的复合结局。次要终点包括通气时间、重症监护病房及住院时长、输血需求、血运重建的完全性、30天手术切口感染以及术前和1年时的神经认知功能。分析遵循意向性治疗原则;估算相对风险及95%置信区间。共纳入508名患者(OPCAB组n=258,ONCAB组n=250;中位年龄68岁[四分位距65.0-73];女性占30.5%)。主要复合结局在OPCAB组28例患者(10.9%)和ONCAB组40例患者(16.0%)中出现(相对风险1.47[95%CI 0.94-2.31];P=0.09)。ONCAB组的手术切口感染发生率更高(20例[8.0%]对比9例[3.5%];P=0.04)。在1年时,神经认知或生活质量方面未观察到显著差异。OPCAB组和ONCAB组的估计1年生存概率分别为96.1%和92.8%(P=0.099)。在进行CABG的预衰弱及衰弱患者中,OPCAB与ONCAB的主要复合结局发生率相似。OPCAB与ONCAB在神经认知结局方面未发现显著差异。
Bronchiectasis is a chronic inflammatory airway disease with limited disease-modifying therapies. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated anti-inflammatory and immunomodulatory effects, but their impact on bronchiectasis outcomes remains unknown. Is GLP-1RA use, compared with dipeptidyl peptidase-4 inhibitor (DPP-4i) or sodium-glucose cotransporter-2 inhibitor (SGLT2i) use, associated with better clinical outcomes in patients with bronchiectasis and type 2 diabetes (T2D)? Using the TriNetX global federated research network, we conducted a retrospective cohort study of patients with bronchiectasis and type 2 diabetes who initiated GLP-1RA therapy between June 1, 2022, and May 30, 2025. We compared clinical outcomes, including all-cause mortality, bronchiectasis exacerbation, acute respiratory failure, and lower respiratory tract infections, with patients receiving DPP-4i) or SGLT2i using propensity score matching to balance baseline characteristics. After propensity score matching, 1,029 patients per group were included in the GLP-1RA versus DPP-4i cohort, and 2,255 patients per group in the GLP-1RA versus SGLT2i cohort. Compared with DPP-4i, GLP-1RA use was associated with significantly lower all-cause mortality (hazard ratio [HR], 0.43; 95% CI, 0.33-0.56) and reduced risks of acute respiratory failure (HR, 0.46; 95% CI, 0.36-0.58) and lower respiratory tract infection (HR, 0.55; 95% CI, 0.46-0.65). Similar benefits were observed compared with SGLT2i for all-cause mortality (HR, 0.49; 95% CI, 0.40-0.60), acute respiratory failure (HR, 0.46; 95% CI, 0.39-0.55), and lower respiratory tract infection (HR, 0.77; 95% CI, 0.68-0.86). Stratified analyses demonstrated consistent mortality benefits across demographic and clinical subgroups, with particularly pronounced effects in obese patients but there was no statistically significant reduction in bronchiectasis exacerbations. Among patients with bronchiectasis and type 2 diabetes, GLP-1RA therapy was associated with significantly lower mortality and reduced respiratory complications compared with DPP-4i or SGLT2i. These findings suggest potential disease-modifying benefits of GLP-1RAs in bronchiectasis beyond glycemic control.
中文摘要:支气管扩张是一种慢性炎症性气道疾病,目前缺乏改变疾病进程的治疗手段。胰高血糖素样肽-1受体激动剂(GLP-1RA)已显示出抗炎和免疫调节作用,但其对支气管扩张预后的影响尚不明确。本研究旨在探讨在支气管扩张合并2型糖尿病(T2D)患者中,与二肽基肽酶-4抑制剂(DPP-4i)或钠-葡萄糖协同转运蛋白2抑制剂(SGLT2i)相比,使用GLP-1RA是否与更好的临床结局相关。利用TriNetX全球联邦研究网络,我们开展了一项回顾性队列研究,纳入2022年6月1日至2025年5月30日期间启动GLP-1RA治疗的支气管扩张合并T2D患者。通过倾向评分匹配平衡基线特征,我们将临床结局(包括全因死亡率、支气管扩张急性加重、急性呼吸衰竭和下呼吸道感染)与接受DPP-4i或SGLT2i治疗的患者进行比较。倾向评分匹配后,GLP-1RA与DPP-4i队列每组纳入1,029名患者,GLP-1RA与SGLT2i队列每组纳入2,255名患者。与DPP-4i相比,使用GLP-1RA与显著降低的全因死亡率(风险比[HR]为0.43;95%置信区间[CI]为0.33-0.56)以及降低的急性呼吸衰竭(HR为0.46;95% CI为0.36-0.58)和下呼吸道感染风险(HR为0.55;95% CI为0.46-0.65)相关。与SGLT2i相比也观察到类似益处,包括全因死亡率(HR为0.49;95% CI为0.40-0.60)、急性呼吸衰竭(HR为0.46;95% CI为0.39-0.55)和下呼吸道感染(HR为0.77;95% CI为0.68-0.86)。分层分析显示,在不同人口统计学和临床亚组中死亡率获益一致,在肥胖患者中效果尤为显著,但支气管扩张急性加重无统计学意义上的降低。在支气管扩张合并T2D患者中,与DPP-4i或SGLT2i相比,GLP-1RA治疗与显著降低的死亡率和减少的呼吸道并发症相关。这些发现提示GLP-1RA在支气管扩张中具有超越血糖控制的潜在疾病修饰益处。
基础研究 (1篇)
Mechanical ventilation is the most widely utilized life support modality worldwide and a necessary, lifesaving intervention in several critical illnesses. Decades of work have elucidated the deleterious impact that injurious ventilator settings have on the lung, which has translated to standard practices of ventilator support that have improved outcomes. Unfortunately, mechanical ventilation is still associated with morbidity and mortality rates that remain unacceptably high. Multiple organ failure is a major cause of death during mechanical ventilation, yet the impact of mechanical ventilation on remote organ systems, such as the brain, heart, and kidney, has received less attention. In this review, we summarize the physiological consequences of mechanical ventilation on extrapulmonary organs and highlight gaps in current knowledge that have precluded the development of novel treatment approaches.
中文摘要:机械通气是全球应用最广泛的生命支持方式,也是多种危重疾病中必要的救命干预措施。数十年的研究阐明了损伤性通气设置对肺部产生的有害影响,这些发现转化为改善预后的标准通气支持实践。然而,机械通气仍与居高不下且不可接受的发病率和死亡率相关。多器官衰竭是机械通气期间死亡的主要原因,但机械通气对脑、心脏和肾脏等远端器官系统的影响却未得到足够重视。本综述总结了机械通气对肺外器官的生理后果,并强调了阻碍新型治疗方法发展的当前知识空白。
3急诊医学与院前急救 (6篇)
临床研究 (5篇)
Survivors of injuries due to violence are at risk for recurrent violent injury (RVI). After an initial violent injury, patients may seek care at multiple different health systems, leading to fragmentation of care, which is a barrier to secondary prevention efforts. To quantify the missed opportunities for secondary prevention efforts in violent injury caused by fragmentation of care. This retrospective cohort study used a regional health information exchange database for a major metropolitan area (Philadelphia, Pennsylvania) from January 1, 2018, through November 30, 2023. Rates of and time to RVI were calculated and then types and locations of visits within the first postinjury year were tabulated. Using multivariable logistic regression, patient and injury factors associated with RVI were identified. Patients with a visit for violent injury between January 1, 2018, through November 30, 2023, were included. Any patients without a full year of follow-up were excluded. These data were analyzed from February 2025 through December 2025. Fragmentation of care. The primary outcome was RVI, defined as having another emergency department, observation or inpatient visit coded for injuries due to interpersonal violence. The association between fragmentation of care and RVI was examined, including the types of visits associated with RVI. Logistic regression modeling also examined demographic and clinical factors, as well as mechanism of injury associated with RVI. Of 26 368 patients with a violent injury (mean [SD] age, 38.0 [14.8] years; 10 456 [39.7%] female and 15 894 [60.3%] male), 2591 (9.8%) recurred within 1 year and 4247 (16.1%) total recurred during the study period. Risk factors for recurrence included initial firearm injury (odds ratio [OR], 3.3; 95% CI, 3.0-3.6), substance use diagnosis (OR, 1.8; 95% CI, 1.6-1.9), and psychiatric diagnoses (OR, 2.4; 95% CI, 2.2-2.6). Among those with RVI, 1701 (40.1%) received treatment for their second violent injury in a different hospital system from their index injury. All patients with RVI (4247) had at least 1 health care encounter between their index and their recurrent injury, 66.0% of which (n = 2803) sought care at multiple institutions during the study period and ultimately, on average, received 42.5% of their care in a health care system different from their index encounter. In this study, recurrent violent injury was common in this major metropolitan area, and single-center studies would have missed at least 40% of recurrences. All patients who went on to recur had additional health care encounters prior to that recurrence, with 66% accessing care in multiple health care systems. This study quantifies the missed opportunities for secondary prevention efforts in violent injury and highlights the importance of collaboration in areas with fragmentation of care.
中文摘要:暴力伤害的幸存者面临再次遭受暴力伤害的风险。初次遭受暴力伤害后,患者可能在多个不同的医疗系统中寻求治疗,导致医疗服务碎片化,这成为二级预防工作的障碍。本研究旨在量化因医疗服务碎片化而错失的暴力伤害二级预防机会。这是一项回顾性队列研究,使用了2018年1月1日至2023年11月30日宾夕法尼亚州费城大都会地区区域健康信息交换数据库的数据。计算了再次暴力伤害的发生率及时间,并统计了受伤后第一年内就诊的类型和地点。利用多变量逻辑回归,确定了与再次暴力伤害相关的患者和伤害因素。纳入2018年1月1日至2023年11月30日期间因暴力伤害就诊的患者。排除随访不足一年的患者。数据于2025年2月至2025年12月进行分析。主要结局为再次暴力伤害,定义为因人际暴力导致的急诊、观察或住院就诊编码。考察了医疗服务碎片化与再次暴力伤害之间的关联,包括与再次暴力伤害相关的就诊类型。逻辑回归模型还分析了人口统计学和临床因素以及导致再次暴力伤害的机制。在26368名暴力伤害患者中(平均年龄38.0岁,标准差14.8;女性10456名占39.7%,男性15894名占60.3%),有2591名(9.8%)在一年内复发,4247名(16.1%)在研究期间总共复发。复发的风险因素包括初始枪伤(比值比3.3,95%置信区间3.0-3.6)、物质使用诊断(比值比1.8,95%置信区间1.6-1.9)和精神疾病诊断(比值比2.4,95%置信区间2.2-2.6)。在再次暴力伤害患者中,有1701名(40.1%)在第二次暴力伤害治疗中选择了与初次伤害不同的医疗系统。所有复发的患者(4247名)在初次伤害和再次伤害之间至少有一次医疗接触,其中66.0%(n=2803)在研究期间在不同机构寻求护理,最终平均有42.5%的护理在与初次接触不同的医疗系统中完成。在本研究中,再次暴力伤害在该大都会地区很常见,单中心研究可能会遗漏至少40%的复发案例。所有复发的患者在复发前都有额外的医疗接触,其中66%在多个医疗系统中接受护理。本研究量化了暴力伤害二级预防工作中错失的机会,并强调了在医疗服务碎片化地区进行合作的重要性。
Household food insecurity (FI) is linked cross-sectionally to diabetes-related outcomes. However, prior studies have not fully considered temporal relationships or the evolving nature of FI. We explored the patterns of FI and associations with hemoglobin A1c (HbA1c), severe hypoglycemia, diabetic ketoacidosis (DKA), health care use, and the ability to obtain diabetes technologies among youth and young adults (YYAs) with youth-onset type 1 diabetes (T1D). Longitudinal data (2016-2022) from 956 YYAs with T1D were analyzed using multivariable logistic and linear regression. Food security was measured thrice (t1, t2, and t3) with the Household Food Security Survey Module and patterned into persistent food security (PFS), intermittent FI (IFI), and persistent FI (PFI). We evaluated FI patterns derived from repeated assessments with follow-up diabetes-related outcomes. The prevalence of IFI was 20.8% and PFI was 7.7%. Compared with YYAs experiencing PFS, the odds of inability to obtain continuous glucose monitors were higher for IFI (1.9, 95% CI 1.1, 3.3) and PFI groups (2.3, 1.0, 5.2), independent of individual characteristics. PFI was additionally associated with higher HbA1c (β = 0.6, P < 0.01), 3.6-fold higher odds of DKA, 3.4-fold higher odds of severe hypoglycemia, 3.1-fold higher odds of HbA1c >9.0%, 3.0-fold higher odds of diabetes-related emergency department visits, and 2.5-fold higher odds of inability to obtain an insulin pump. Among YYAs with T1D, IFI and PFI over time both seem to be associated with severely impaired ability to maintain glycemic targets, increasing the risk of adverse outcomes.
中文摘要:家庭粮食不安全与糖尿病相关结局存在横断面关联,但既往研究未充分考量时间关系及粮食不安全状态的演变特征。本研究探讨了青年及年轻成人(YYA)中青少年起病1型糖尿病患者的粮食不安全模式及其与糖化血红蛋白、严重低血糖、糖尿病酮症酸中毒、医疗利用及获取糖尿病技术能力的关联。分析2016至2022年间956名T1D YYA的纵向数据,采用多变量逻辑回归和线性回归模型。通过家庭粮食安全调查模块在三个时间点测量粮食安全状态,并将其划分为持续粮食安全、间歇性粮食不安全及持续性粮食不安全模式。评估重复评估得出的粮食不安全模式与随访糖尿病相关结局的关系。结果显示,间歇性粮食不安全患病率为20.8%,持续性粮食不安全为7.7%。与经历持续安全状态的YYA相比,间歇性和持续性粮食不安全组获取连续血糖监测仪的能力受限风险更高,比值比分别为1.9和2.3,且独立于个体特征。此外,持续性粮食不安全还与较高的糖化血红蛋白水平、糖尿病酮症酸中毒风险增加3.6倍、严重低血糖风险增加3.4倍、糖化血红蛋白大于9.0%的风险增加3.1倍、糖尿病相关急诊就诊风险增加3.0倍以及获取胰岛素泵能力受限风险增加2.5倍相关。在T1D YYA中,随时间变化的间歇性和持续性粮食不安全似乎均与维持血糖目标能力的严重受损相关,增加了不良结局的风险。
The electrocardiogram (ECG) is an established tool in cardiovascular prevention, identifying silent arrhythmias, hypertrophy, prior myocardial infarction, conduction disease, and inherited electrical disorders. However, conventional interpretation captures only a fraction of the information embedded in the cardiac electrical signal. Because the ECG is inexpensive, non-invasive, standardized, and already acquired at scale, it provides an attractive substrate for artificial intelligence (AI)-enabled screening and risk stratification. Deep-learning models can identify latent signatures of ventricular dysfunction, structural heart disease, atrial fibrillation, cardiomyopathy, heart failure, and mortality risk. Importantly, evidence is beginning to extend beyond retrospective validation: prospective implementation studies have increased disease detection, while randomized data suggest that AI-ECG-guided clinical alerts may improve outcomes in selected high-risk populations. Whether such benefits extend to preventive populations remains uncertain. This review examines the preventive role of conventional, ambulatory, and wearable ECGs and distinguishes AI applications for detection, prediction, prognostication, treatment selection, and longitudinal monitoring. We argue that performance metrics alone are insufficient. Preventive value requires a defined target population, calibrated and externally validated predictions, an appropriate confirmatory test, a feasible clinical workflow, and an intervention proven to improve outcomes. The most credible near-term applications are those that triage patients to established diagnostic pathways, such as echocardiography or prolonged rhythm monitoring. The central challenge is therefore to transform accurate AI-ECG predictions into actionable, affordable, scalable, safe, and equitable prevention.
中文摘要:心电图是心血管预防的既定工具,可识别隐匿性心律失常、心肌肥厚、既往心肌梗死、传导疾病及遗传性电生理紊乱。然而,传统解读仅能捕捉心脏电信号中嵌入信息的一小部分。由于心电图具有低成本、无创、标准化且已大规模采集的特点,它成为人工智能筛查和风险分层的理想基础数据。深度学习模型能够识别心室功能障碍、结构性心脏病、心房颤动、心肌病、心力衰竭及死亡风险的潜在特征。目前证据已开始超越回顾性验证:前瞻性实施研究提高了疾病检出率,随机数据表明人工智能心电图引导的临床警报可能改善特定高危人群的预后。此类益处是否延伸至预防性人群仍不确定。本综述考察了常规、动态及可穿戴心电图的预防作用,并区分了人工智能在检测、预测、预后判断、治疗选择及纵向监测中的应用。我们认为仅凭性能指标不足够,预防价值需具备明确的目标人群、校准且经外部验证的预测模型、合适的确认性检测手段、可行的临床工作流以及被证实能改善预后的干预措施。最可信的近期应用是将患者分流至既定诊断路径,如超声心动图或延长节律监测。核心挑战在于将准确的人工智能心电图预测转化为可操作、负担得起、可扩展、安全且公平预防措施。
Among 3695 matched pairs with same-date emergency department contact, retinal artery occlusion was associated with lower brain imaging use (77.3% versus 91.7%) and slightly higher cervical imaging use (81.7% versus 79.2%) than transient ischemic attack.
中文摘要:在3695对急诊就诊日期相同的匹配病例中,与短暂性脑缺血发作相比,视网膜动脉阻塞患者的脑部影像检查使用率较低(77.3%对比91.7%),而颈部影像检查使用率略高(81.7%对比79.2%)。
Opportunities to practice low-frequency skills for high-acuity pediatric emergency procedures in clinical settings are limited. The Basic Emergency Skills Techniques 3N1 (BEST 3N1) workshop was designed as a structured, hands-on training program to support procedural skill development among pediatric emergency care practitioners. This study aimed to evaluate preworkshop to postworkshop changes in procedural performance and knowledge after a 3-day hands-on pediatric emergency skills workshop. A quasi-experimental prospective pre-post interventional study was conducted during the 8th BEST 3N1 workshop, held from February 11 to 13, 2025, at the Simulation and Skills Development Centre, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. The workshop included 24 scheduled continuing medical education hours in 3 domains: wound suturing, pediatric airway management, and pediatric orthopedic emergencies and casting. Procedural performance was assessed using complete paired preworkshop and postworkshop data for each assessment. Day 1 wound suturing and day 2 airway management were assessed using 4-item checklists scored from 0 to 8. Day 3 orthopedic casting competence was assessed using a keyword-based rubric covering equipment, procedural steps, and postapplication care, with a total score range of 0 to 30. Written knowledge was assessed using a 30-item multiple-choice test. The number of paired observations differed in assessments because the analysis was based on complete matched preworkshop and postworkshop data for each outcome. Day 1 wound suturing checklist mean scores increased from 4.14 (SD 1.72) to 7.72 (SD 0.68) among 88 paired participants, with a mean change of 3.58 (SD 1.71; P<.001) points. Day 2 airway management checklist scores increased from 5.47 (SD 1.88) to 7.81 (SD 0.56) among 77 paired participants, with a mean change of 2.34 (SD 1.96; P<.001) points. Day 3 orthopedic casting total competence scores increased from 4.20 to 6.39 among 77 paired participants, with a mean change of 2.19 (SD 1.72; 95% CI 1.80-2.58; P<.001). Written knowledge scores increased from 19.04 (SD 3.77) to 22.32 (SD 3.23) among 94 paired participants, with a mean change of 3.28 (95% CI 2.16-4.39; P<.001) points. The BEST 3N1 workshop was associated with improved checklist-based procedural performance, orthopedic casting competence, and written knowledge among pediatric emergency care practitioners. These findings support the use of structured hands-on workshops for high-acuity, low-frequency pediatric emergency skills.
中文摘要:在临床环境中练习高频急症儿科急救的低频技能机会有限。基础急诊技能技术3N1(BEST 3N1)研讨会被设计为一种结构化的动手培训项目,以支持儿科急诊护理从业者的程序性技能发展。本研究旨在评估为期三天的动手儿科急诊技能研讨会前后,程序性表现和知识的变化。一项准实验前瞻性前后干预研究于2025年2月11日至13日在沙特阿拉伯利雅得的公主努拉·宾特·阿卜杜勒拉赫曼大学模拟与技能发展中心举行的第8届BEST 3N1研讨会期间开展。该研讨会包含24个计划的继续医学教育小时,涵盖三个领域:伤口缝合、儿科气道管理和儿科骨科急症及固定。程序性表现通过每个评估的完整配对前后数据进行评估。第1天的伤口缝合和第2天的气道管理使用评分为0至8的四项检查表进行评估。第3天的骨科固定能力使用基于关键词的量表进行评估,涵盖设备、程序步骤和固定后护理,总分范围为0至30。书面知识通过30道多项选择题测试进行评估。配对观察数量在评估中有所不同,因为分析基于每个结果的完整匹配前后数据。在第88对参与者中,第1天伤口缝合检查表的平均分从4.14(标准差1.72)增加到7.72(标准差0.68),平均变化为3.58(标准差1.71;P<.001)分。在第77对参与者中,第2天气道管理检查表分数从5.47(标准差1.88)增加到7.81(标准差0.56),平均变化为2.34(标准差1.96;P<.001)分。在第77对参与者中,第3天骨科固定总能力分数从4.20增加到6.39,平均变化为2.19(标准差1.72;95%置信区间1.80-2.58;P<.001)。在第94对参与者中,书面知识分数从19.04(标准差3.77)增加到22.32(标准差3.23),平均变化为3.28(95%置信区间2.16-4.39;P<.001)分。BEST 3N1研讨会与儿科急诊护理从业者的基于检查表的程序性表现、骨科固定能力和书面知识的改善相关。这些发现支持使用结构化的动手研讨会进行高急症度、低频次的儿科急诊技能训练。
基础研究 (1篇)
Rapid, accurate, and multiplexed point-of-care testing (POCT) of respiratory pathogens is critical for clinical triage and infection control. However, existing platforms frequently necessitate trade-offs between sensitivity, throughput, and operational complexity. To address this, we developed the iCARD (integrated Centrifugal Assay on a Rotating Disc) platform, a streamlined microfluidic molecular diagnostic system based on single-step CRISPR kinetics and centrifugal microfluidics. Comprising a polymethyl methacrylate disc pre-loaded with lyophilized CRISPR/Cas13a reagents and a self-developed portable fluorescence analyzer, the platform enables automated multiplexed detection following sample loading. Furthermore, a novel resin-based pretreatment method was engineered to efficiently purify and concentrate nucleic acids from throat swabs. The iCARD system facilitates the parallel screening of six respiratory pathogens across four independent samples within 40 min. Analytical validation confirmed single-copy sensitivity (limit of detection: 0.25-1.0 copies/μL) without cross-reactivity. Clinical validation using 94 retrospective patient throat swabs demonstrated exceptional diagnostic accuracy, achieving a sensitivity of 95.5% (64/67; 95% CI: 87.64%-98.47%) and a specificity of 100.0% (27/27; 95% CI: 87.51%-100.00%). These findings demonstrate that the iCARD platform serves as a robust, high-throughput, and accurate diagnostic tool for decentralized molecular screening and epidemiological surveillance.
中文摘要:呼吸道病原体的快速、准确且多重化的即时检测(POCT)对于临床分诊和感染控制至关重要。然而,现有平台往往需要在灵敏度、通量和操作复杂性之间做出权衡。为解决这一问题,我们开发了iCARD(集成式旋转盘离心微流控分析平台),这是一种基于单步CRISPR动力学和离心微流控技术的简化分子诊断系统。该平台由预装冻干CRISPR/Cas13a试剂的聚甲基丙烯酸甲酯圆盘和自主研发便携式荧光分析仪组成,在样本加载后可实现自动化的多重检测。此外,我们设计了一种新型树脂基预处理方法,用于从咽拭子中高效纯化并浓缩核酸。iCARD系统可在40分钟内对四个独立样本中的六种呼吸道病原体进行平行筛查。分析验证确认了其单拷贝灵敏度(检出限:0.25-1.0 copies/μL)且无交叉反应。利用94份回顾性患者咽拭子进行的临床验证显示出卓越的诊断准确性,敏感性为95.5%(64/67;95% CI: 87.64%-98.47%),特异性为100.0%(27/27;95% CI: 87.51%-100.00%)。这些发现表明,iCARD平台是一种稳健、高通量且准确的诊断工具,适用于去中心化分子筛查和流行病学监测。
4脓毒症与感染性休克 (5篇)
临床研究 (2篇)
Severe COVID-19 is characterised by maladaptive host inflammation. In the SAVE-MORE trial (EudraCT no. 2020-005828-11; ClinicalTrials.gov NCT04680949), suPAR-guided anakinra treatment reduced mortality and progression to severe respiratory failure (SRF), but the underlying molecular mechanisms remain unclear. We performed longitudinal proteomic profiling (Olink Inflammation panel, 67 proteins) in 587 SAVE-MORE participants (400 treated with anakinra and 187 with placebo), of whom 453 had samples at all three time points (baseline, Day 4, and Day 7). Analyses aimed to (i) identify baseline predictors of SRF, (ii) define inflammatory trajectories using mixed-effects models, and (iii) characterise proteomic changes at SRF onset. Cox models identified prognostic markers, validated in an independent anakinra-treated cohort from the SAVE trial (n = 153). Multivariate Cox regression models adjusted for sex, age, BMI, and dexamethasone treatment showed that baseline IL-6 concentrations predicted SRF across both treatment arms (placebo HR = 1·99, CI: 1·31-3·02; anakinra HR = 2·12, CI: 1·56-2·87), while PD-L1 predicted SRF only in the placebo group (HR = 2·75, CI: 1·79-4·24). Anakinra allocation was associated with changes in inflammatory trajectories related to SRF progression. Patients developing SRF showed sustained activation marked by elevated concentrations of IL-6, MCP-1/3, EN-RAGE, and PD-L1, whereas SRF-free patients had higher levels of proteins linked to regulatory and adaptive immunity, including CD6, CD244, TRAIL, TNF-B, and FLT3L. Event-aligned analyses showed an acute inflammatory surge at SRF onset involving IL-6, CXCL5, OSM, and VEGFA, which was significantly attenuated by anakinra. Results were further confirmed in the SAVE cohort. Progression to SRF was associated with an inflammatory amplification programme involving cytokine, chemokine, tissue-injury, and immune-checkpoint pathways. Anakinra allocation was associated with smaller changes in proteins associated with inflammatory amplification and acute inflammatory changes accompanying respiratory deterioration. These findings provide biological context for the clinical benefit observed in the SAVE-MORE trial. Hellenic Institute for the Study of Sepsis (sponsor) and Swedish Orphan Biovitrum (funder).
中文摘要:COVID-19中炎症蛋白轨迹与重度呼吸衰竭:SAVE-MORE随机试验的二次分析。重度COVID-19以宿主适应不良性炎症为特征。在SAVE-MORE试验(EudraCT编号2020-005828-11;ClinicalTrials.gov NCT04680949)中,suPAR指导的阿那白滞素治疗降低了死亡率及进展至重度呼吸衰竭(SRF)的风险,但其潜在分子机制仍不清楚。我们对587例SAVE-MORE参与者(400例接受阿那白滞素治疗,187例接受安慰剂)进行了纵向蛋白质组学分析(Olink炎症面板,67种蛋白),其中453例在所有三个时间点(基线、第4天和第7天)均有样本。分析旨在(i)识别SRF的基线预测因素,(ii)使用混合效应模型定义炎症轨迹,(iii)描述SRF发生时的蛋白质组学变化。Cox模型识别了预后标志物,并在SAVE试验中一个独立的阿那白滞素治疗队列(n=153)中进行了验证。校正性别、年龄、BMI和地塞米松治疗的多变量Cox回归模型显示,基线IL-6浓度在两个治疗组中均预测SRF(安慰剂HR=1·99,CI:1·31-3·02;阿那白滞素HR=2·12,CI:1·56-2·87),而PD-L1仅在安慰剂组中预测SRF(HR=2·75,CI:1·79-4·24)。分配至阿那白滞素与SRF进展相关炎症轨迹的变化相关。发生SRF的患者表现出持续激活,标志为IL-6、MCP-1/3、EN-RAGE和PD-L1浓度升高,而未发生SRF的患者具有较高水平的与调节性免疫和适应性免疫相关的蛋白,包括CD6、CD244、TRAIL、TNF-B和FLT3L。事件对齐分析显示,SRF发生时出现涉及IL-6、CXCL5、OSM和VEGFA的急性炎症激增,且该激增被阿那白滞素显著减弱。结果在SAVE队列中进一步得到证实。进展至SRF与涉及细胞因子、趋化因子、组织损伤和免疫检查点通路的炎症放大程序相关。分配至阿那白滞素与炎症放大相关蛋白的变化较小以及伴随呼吸恶化的急性炎症变化较小相关。这些发现为SAVE-MORE试验中观察到的临床获益提供了生物学背景。Hellenic Institute for the Study of Sepsis(申办方)和Swedish Orphan Biovitrum(资助方)。
To identify subgroups of patients hospitalized for community-acquired sepsis without initial organ support who may derive survival and cost-effectiveness benefits from ICU or high-dependency care unit (HDU) admission. Retrospective cohort study. A 140-hospital Japanese database (April 2016-March 2024). Adults admitted via emergency ambulance for community-acquired sepsis not requiring extracorporeal membrane oxygenation, mechanical ventilation, catecholamines, or renal replacement therapy before or on the antimicrobial-initiation day. None. We compared ICU and HDU admissions, each vs. general ward (GW) admission, balancing patient characteristics using overlap propensity-score weighting. In-hospital mortality was estimated as risk ratios (RRs) with 95% CIs using modified Poisson regression. Cost-effectiveness was measured by the incremental cost-effectiveness ratio (ICER) in 3-year costs per quality-adjusted life year (QALY). Among 28,211 patients (GW, 18,349; HDU, 8,706; ICU, 1,156), ICU and HDU admissions were not associated with lower mortality overall (HDU vs. GW; RR, 0.99; 95% CI, 0.92-1.06 and ICU vs. GW; RR, 1.06; 95% CI, 0.92-1.22). However, HDU admission was associated with lower mortality among patients with Sequential Organ Failure Assessment (SOFA) score greater than or equal to 6 (RR, 0.86; 95% CI, 0.75-0.99) or Glasgow Coma Scale (GCS) score less than or equal to 12 (RR, 0.81; 95% CI, 0.71-0.92). Under the Japanese (50,000 USD/QALY) and U.S. (100,000 USD/QALY) thresholds, ICU and HDU admissions were not cost-effective overall (ICERs > 200,000 USD/QALY). However, the HDU subgroup with GCS score less than or equal to 12 (ICER, 47,738 USD/QALY; 95% CI, 45,918-49,558) was cost-effective under both thresholds, and that with SOFA score greater than or equal to 6 (ICER, 55,319 USD/QALY; 95% CI, 52,018-58,624) met the U.S. threshold. ICU or HDU admission was not associated with survival or economic benefits overall, whereas HDU subgroups (SOFA score ≥ 6 or GCS score ≤ 12) were associated with lower mortality and better cost-effectiveness. These findings may help optimize resource allocation.
中文摘要:目的:明确社区获得性脓毒症且初始无需器官支持的患者中,哪些亚组可从重症监护室(ICU)或高依赖护理单元(HDU)的收治中获得生存和成本效益优势。方法:回顾性队列研究。数据来源于日本140家医院的数据库(2016年4月至2024年3月)。纳入通过急救救护车入院、在启动抗菌药物当天或之前无需体外膜肺氧合、机械通气、血管活性药物或肾脏替代治疗的社区获得性脓毒症成人患者。分析比较了ICU和高依赖护理单元(HDU)收治与一般病房(GW)收治的差异,采用重叠倾向评分加权法平衡患者特征。使用修正泊松回归估算院内死亡率的风险比(RR)及95%置信区间(CI)。成本效益通过每质量调整生命年(QALY)3年的增量成本效益比(ICER)衡量。结果:在28,211名患者中(GW 18,349人;HDU 8,706人;ICU 1,156人),总体而言,ICU和HDU收治与较低的死亡率无关联(HDU对比GW:RR 0.99;95% CI 0.92-1.06;ICU对比GW:RR 1.06;95% CI 0.92-1.22)。然而,对于序贯器官衰竭评估(SOFA)评分大于等于6分或格拉斯哥昏迷量表(GCS)评分小于等于12分的患者,HDU收治与较低的死亡率相关(SOFA≥6:RR 0.86;95% CI 0.75-0.99;GCS≤12:RR 0.81;95% CI 0.71-0.92)。在日本(50,000美元/QALY)和美国(100,000美元/QALY)的阈值下,ICU和HDU收治在整体上不具备成本效益(ICER>200,000美元/QALY)。然而,GCS评分小于等于12分的HDU亚组在两种阈值下均具备成本效益(ICER 47,738美元/QALY;95% CI 45,918-49,558),SOFA评分大于等于6分的亚组达到了美国阈值标准(ICER 55,319美元/QALY;95% CI 52,018-58,624)。结论:总体而言,ICU或HDU收治并未带来生存或经济优势,但SOFA评分≥6分或GCS评分≤12分的HDU亚组与较低的死亡率和更好的成本效益相关。这些发现有助于优化资源配置。
基础研究 (3篇)
Sepsis-induced immunosuppression is a major cause of secondary infection and mortality, yet the mechanisms governing dendritic cell (DC) dysfunction and loss remain incompletely understood. Here, we identify lysophosphatidic acid receptor 5 (LPAR5) as a critical regulator of DC survival and immune competence during sepsis. Integrative analysis of septic murine transcriptomic datasets and qRT‒PCR profiling of peripheral blood from patients with sepsis revealed the conserved upregulation of LPAR5, predominantly in conventional DCs (cDCs) in mice, and lower LPAR5 expression was associated with greater disease severity. Conditional deletion of Lpar5 in cDCs accelerated DC depletion, impaired DC maturation and antigen presentation, diminished naive CD4+ T-cell priming, and exacerbated bacterial burden, secondary infection, and mortality. Single‑cell RNA sequencing of splenic DCs from LPAR5‑deficient mice revealed that excessive stimulator of interferon genes (STING)‑type I interferon signaling with two parallel features, namely, ferroptotic death of cDCs and the emergence of an immunosuppressive interferon‑stimulated gene‑positive (ISG+) cDC2 subset, exacerbated immune paralysis. Mechanistically, LPAR5 interacts with the C-terminal tail of STING, limiting TANK-binding kinase 1 (TBK1) recruitment and restraining STING-dependent lipid peroxidation and ferroptotic death. Pharmacological inhibition of ferroptosis in vivo and of STING or TBK1 signaling in vitro restored DC survival. These findings define a previously unrecognized LPAR5-STING-TBK1 axis that safeguards DC homeostasis and identify the ISG+ cDC2 subset as a pathogenic contributor to sepsis-induced immunosuppression, highlighting LPAR5 as a potential therapeutic target to preserve antimicrobial immunity in sepsis.
中文摘要:脓毒症诱导的免疫抑制是继发感染和死亡的主要原因,但调控树突状细胞功能障碍和丢失的机制尚不完全清楚。本研究鉴定出溶血磷脂酸受体5(LPAR5)是脓毒症期间维持树突状细胞存活和免疫能力的关键调节因子。通过对脓毒症小鼠转录组数据集的综合分析以及脓毒症患者外周血的qRT-PCR谱系分析,发现LPAR5在保守性上调,主要存在于小鼠的常规树突状细胞中,且较低的LPAR5表达与更严重的疾病严重程度相关。条件性敲除常规树突状细胞中的Lpar5会加速树突状细胞耗竭,损害其成熟和抗原呈递能力,削弱初始CD4+ T细胞的致敏作用,并加重细菌负荷、继发感染和死亡率。对LPAR5缺陷小鼠脾脏树突状细胞进行单细胞RNA测序显示,过度的干扰素基因刺激因子(STING)I型干扰素信号传导具有两个平行特征,即树突状细胞的铁死亡和免疫抑制性干扰素刺激基因阳性(ISG+)cDC2亚群的出现,加剧了免疫麻痹。在机制上,LPAR5与STING的C端尾部相互作用,限制TANK结合激酶1(TBK1)的招募并抑制STING依赖性的脂质过氧化和铁死亡。体内铁死亡的药理学抑制以及体外STING或TBK1信号通路的抑制均恢复了树突状细胞的存活。这些发现定义了一个先前未被认识的LPAR5-STING-TBK1轴,该轴保护树突状细胞稳态,并将ISG+ cDC2亚群确定为脓毒症诱导免疫抑制的致病贡献者,突显了LPAR5作为在脓毒症中维持抗菌免疫潜力的治疗靶点。
Mammalian nitric oxide synthase (NOS) generates nitric oxide (NO), an essential signaling molecule in neurotransmission, inflammation and cardiovascular regulation. NOS dysregulation contributes to neurodegeneration, septic shock and ischemia. The structural basis of NOS function remains unclear, likely because of its dynamic, multicomponent architecture. Catalysis requires electron transfer across five cofactors, with the oxygenase (Oxy) domain converting L-arginine to NO after receiving electrons from the reductase (Red) domain through calmodulin (CaM) activation. Here, we report cryo-electron microscopy structures of the human inducible NOS:CaM holoenzyme, revealing an architecture in which the Red:CaM arm spans the Oxy dimer in an apparent active state for cross-monomer electron transfer. The flavin mononucleotide subdomain is rotated ~90° relative to the Red core, positioning its cofactor ~9 Å from the heme, adjacent to a conserved tryptophan residue within a narrow Oxy domain tunnel. Red-Oxy flexibility in the active state may facilitate electron shuttling among cofactors, defining how NOS cofactors are transiently aligned to enable catalysis.
中文摘要:哺乳动物一氧化氮合酶(NOS)产生一氧化氮(NO),后者是神经传递、炎症和心血管调节中的关键信号分子。NOS功能失调会导致神经退行性变、脓毒性休克和缺血。NOS功能的结构基础尚不清楚,这可能是因为其具有动态的多组分架构。催化作用需要电子在五个辅因子之间转移,其中氧化酶(Oxy)结构域在接收来自还原酶(Red)结构域的电子后,将L-精氨酸转化为NO,该过程依赖于钙调蛋白(CaM)的激活。本研究报道了人诱导型NOS:CaM全酶复合物的冷冻电镜结构,揭示了一种架构:Red:CaM臂跨越Oxy二聚体,处于跨单体电子转移的表观活性状态。黄素单核苷酸亚结构域相对于Red核心旋转约90°,使其辅因子位于距血红素约9Å处,紧邻狭窄Oxy结构域隧道内的一个保守色氨酸残基。活性状态下Red-Oxy的灵活性可能促进辅因子间的电子穿梭,定义了NOS辅因子如何瞬时排列以实现催化作用。
Sepsis-associated acute kidney injury (SA-AKI) is a severe condition characterized by dysregulated inflammatory responses. Transfer RNA-derived small RNAs (tsRNAs), including transfer RNA-derived fragments (tRFs) and transfer RNA halves (tiRNAs), have emerged as regulators of pathological processes in the kidney. However, their roles in SA-AKI remain unclear. To help define this, tRF and tiRNA sequencing was conducted to screen dysregulated tsRNAs in lipopolysaccharide (LPS)-induced SA-AKI in male C57BL/6J mouse kidneys. tiRNA-1:34-Asp-GTC-2 (tiRNA-Asp) was identified as a potential tsRNA candidate. Its expression was quantified using qRT-PCR and its localization was examined by fluorescence in situ hybridization. tiRNA-Asp was silenced in vivo using the antagomir to assess its function in LPS-induced AKI. The biodistribution of Cy7-labeled tiRNA-Asp antagomir was assessed by in vivo and ex vivo fluorescence imaging. Mouse kidney tubular epithelial cells were transfected with tiRNA-Asp mimics or inhibitors to evaluate its pro-inflammatory effects. RNA-seq, dual-luciferase reporter assays, RNA pulldown assays, and rescue experiments were performed to identify downstream targets and elucidate the mechanisms of tiRNA-Asp. tiRNA-Asp showed the most pronounced upregulation in SA-AKI kidneys and was predominantly localized in tubular epithelial cells. It was consistently upregulated across different AKI models. In vivo inhibition of tiRNA-Asp with antagomir alleviated LPS- and ischemia-induced inflammatory responses and kidney injury while suppressing nuclear factor-κB (NF-κB) activation. In kidney tubular epithelial cells, tiRNA-Asp overexpression promoted NF-κB activity and enhanced inflammatory cytokine expression, whereas tiRNA-Asp knockdown suppressed NF-κB activation and reduced cytokine production. Mechanistically, sucrose nonfermenting-related kinase (SNRK), a key anti-inflammatory regulator, was identified as a direct target of tiRNA-Asp. tiRNA-Asp enhanced NF-κB activation and inflammatory responses by downregulating SNRK expression. Angiogenin and ribonuclease inhibitor 1 are associated with tiRNA-Asp biogenesis during sepsis. Our study reveals a novel pro-inflammatory tiRNA involved in the pathogenesis of SA-AKI and demonstrates that the tiRNA-Asp/SNRK/NF-κB pathway may represent a potential therapeutic target for sepsis-induced inflammation and AKI.
中文摘要:脓毒症相关急性肾损伤SA-AKI是一种以炎症反应失调为特征的严重疾病。转移RNA衍生小RNAtsRNAs包括tRF和tiRNA已成为肾脏病理过程的调节因子但其作用尚不明确。本研究通过测序筛选脂多糖LPS诱导的SA-AKI小鼠肾脏中差异表达的tsRNA鉴定出tiRNA-1:34-Asp-GTC-2即tiRNA-Asp作为潜在候选分子。利用qRT-PCR定量其表达并通过荧光原位杂交检测其定位。在体内使用反义寡核苷酸antagomir沉默tiRNA-Asp以评估其在LPS诱导的AKI中的功能并通过活体及离体荧光成像评估Cy7标记的tiRNA-Asp antagomir的生物分布。在小鼠肾小管上皮细胞中转染tiRNA-Asp模拟物或抑制剂以评估其促炎作用。通过RNA-seq双荧光素酶报告基因检测RNA pull-down实验和挽救实验确定下游靶点并阐明机制。结果显示tiRNA-Asp在SA-AKI肾脏中显著上调且主要定位于肾小管上皮细胞在不同AKI模型中均持续上调。体内抑制tiRNA-Asp可减轻LPS及缺血诱导的炎症反应和肾损伤并抑制NF-κB活化。在肾小管上皮细胞中过表达tiRNA-Asp促进NF-κB活性并增强炎症因子表达而敲低tiRNA-Asp则抑制NF-κB活化并减少细胞因子产生。机制上发现蔗糖非发酵相关激酶SNRK作为关键抗炎调节因子是tiRNA-Asp的直接靶点tiRNA-Asp通过下调SNRK表达增强NF-κB活化和炎症反应。血管生成素和核糖核酸酶抑制剂1与脓毒症期间tiRNA-Asp的生物发生有关。本研究揭示了一种参与SA-AKI发病机制的新型促炎tiRNA并表明tiRNA-Asp/SNRK/NF-κB通路可能是治疗脓毒症诱导的炎症和AKI的潜在靶点。
5创伤与急诊外科 (2篇)
临床研究 (2篇)
To determine the point prevalence of coma across Latin American critical care units, characterize its etiology, and explore short-term outcomes. Multinational, cross-sectional point prevalence study with exploratory 14-day follow-up assessment. Three hundred ninety-two hospitals across 19 Latin American countries, including ICUs, intermediate care units, neurocritical care units, cardiovascular ICUs, and trauma ICUs. Adult patients (≥ 18 yr) meeting the Coma Epidemiology, Evaluation, and Therapy care survey (COME-TOGETHER) criteria on May 28, 2024. Patients under deep sedation or pharmacological coma induction were excluded unless the coma state preceded pharmacological intervention. None (observational study). Among 8305 critically ill patients, 1145 met coma criteria (point prevalence 13.8%), with country-specific rates ranging from 5.1% to 36.8%. Individual patient data were available for 729 patients (63.7%). Traumatic brain injury was the leading individual cause (24.8%), followed by hypoxic-anoxic brain injury (14.6%) and intracerebral hemorrhage (13.5%). When categorized by pathophysiology, vascular causes predominated (48.6%), followed by traumatic brain injury (24.8%) and other causes (26.6%). Age-stratified analysis revealed trauma predominantly affecting younger patients, while cerebrovascular causes predominated in older groups. Among patients with 14-day follow-up data (29% of cohort), mortality was 29.2%, with 67.7% of survivors recovering from coma. Only the Charlson Comorbidity Index was independently associated with implementation of life-sustaining therapy limitations (adjusted odds ratio, 1.22; 95% CI, 1.15-1.30; p < 0.001). Coma affects nearly one in seven ICU beds across Latin America, with substantial country variation and distinct age-dependent etiology patterns. The significant burden highlights the need for targeted prevention strategies and specialized neurocritical care resources throughout the region.
中文摘要:目的:确定拉丁美洲重症监护病房中昏迷的点患病率,描述其病因并探索短期预后。设计:跨国横断面点患病率研究,附带探索性14天随访评估。地点:涵盖19个拉丁美洲国家的392家医院,包括ICU、中间护理单元、神经重症监护单元、心血管ICU和创伤ICU。参与者:2024年5月28日符合昏迷流行病学、评估和治疗护理调查(COME-TOGETHER)标准的成人患者(≥18岁)。排除深度镇静或药物诱导昏迷的患者,除非昏迷状态发生在药物干预之前。类型:观察性研究。结果:在8305名危重患者中,1145人符合昏迷标准(点患病率13.8%),各国具体比率从5.1%到36.8%不等。729名患者的个体数据可用(占63.7%)。创伤性脑损伤是主要的单一病因(24.8%),其次是缺氧缺血性脑损伤(14.6%)和脑出血(13.5%)。按病理生理学分类,血管性原因占主导地位(48.6%),其次是创伤性脑损伤(24.8%)和其他原因(26.6%)。年龄分层分析显示,创伤主要影响年轻患者,而脑血管原因在老年群体中占主导地位。在拥有14天随访数据的患者中(占队列的29%),死亡率为29.2%,幸存者的昏迷恢复率为67.7%。只有查尔森合并症指数与实施生命维持治疗限制独立相关(调整比值比1.22;95%置信区间1.15-1.30;p < 0.001)。结论:拉丁美洲近七分之一ICU床位受昏迷影响,存在显著的国别差异和独特的年龄依赖性病因模式。这一重大负担凸显了该地区需要针对性的预防策略和专门的神经重症护理资源。
To compare the analgesic efficacy and safety of ultrasound-guided suprascapular nerve block with intravenous fentanyl in patients with traumatic scapular fractures. We conducted an open-label randomized controlled pilot trial in the emergency department (ED) of a Level I trauma center in North India. Adults with traumatic scapular fractures and Defense and Veterans Pain Rating Scale scores of 7 and higher, were randomly assigned to ultrasound-guided suprascapular nerve block or intravenous fentanyl (1 μg/kg). Pain scores were assessed at baseline and 30, 60, 120, 240, and 360 minutes. Secondary outcomes included rescue analgesia and adverse events. Sixty patients were randomly assigned to the 2 groups. Median baseline pain score was 10 in both groups. Pain scores were consistently lower with suprascapular nerve block, with median scores of 3 (interquartile [IQR] 2 to 5) versus 7 (IQR 6 to 8) at 30 minutes. Between-group differences were 4 (95% confidence interval [CI], 3 to 4) at 30 and 60 minutes, 2 (95% CI, 2 to 2) at 120 and 240 minutes, and 1 (95% CI, 1 to 2) at 360 minutes. Rescue analgesia was less frequent with suprascapular nerve block (13% versus 79%; risk difference, -66% [95% CI, 47.5 to 85.2]). Drowsiness was more common with fentanyl (12 versus 2 participants); hypotension occurred in 1 fentanyl recipient and paresthesia in 1 suprascapular nerve block recipient. In this pilot randomized trial, ultrasound-guided suprascapular nerve block provided greater and sustained pain relief, reduced rescue analgesia, and fewer systemic adverse effects than intravenous fentanyl in adults with traumatic scapular fractures. Larger multicenter trials are needed to confirm these findings and evaluate cumulative opioid use and longer-term outcomes.
中文摘要:比较超声引导下肩胛上神经阻滞与静脉注射芬太尼治疗创伤性肩胛骨骨折患者的镇痛疗效和安全性。我们在印度北部一家一级创伤中心的急诊科开展了一项开放标签随机对照试点试验。入选对象为患有创伤性肩胛骨骨折且防御与退伍军人疼痛评定量表评分大于等于7分的成年人,随机分配至超声引导下肩胛上神经阻滞组或静脉注射芬太尼组(1 μg/kg)。在基线及30、60、120、240和360分钟时评估疼痛评分。次要结局包括补救性镇痛和不良事件。共60名患者随机分配至两组。两组的基线中位疼痛评分均为10分。肩胛上神经阻滞组的疼痛评分始终较低,30分钟时中位评分为3(四分位距2至5),而芬太尼组为7(四分位距6至8)。组间差异在30和60分钟时为4(95%置信区间3至4),120和240分钟时为2(95%置信区间2至2),360分钟时为1(95%置信区间1至2)。肩胛上神经阻滞组需要补救性镇痛的比例较低(13%对79%;风险差异-66% [95%置信区间47.5至85.2])。芬太尼组嗜睡更常见(12例对2例);1例芬太尼使用者出现低血压,1例肩胛上神经阻滞使用者出现感觉异常。在本试点随机试验中,与静脉注射芬太尼相比,超声引导下肩胛上神经阻滞为创伤性肩胛骨骨折成年人提供了更大且更持久的镇痛效果,减少了补救性镇痛需求,并减少了全身性不良反应。需要开展更大规模的多中心试验以证实这些发现,并评估累积阿片类药物使用量和长期结局。
6中毒与环境急症 (2篇)
基础研究 (2篇)
Achieving 4-electron oxygen reduction with metal-free electrodes has remained a longstanding challenge. Here, we show that poly(benzimidazobenzophenanthroline) (BBL), an n-type ladder polymer, breaks this barrier through an electrocatalytic inner-sphere 2 + 2 series mechanism─a mode of reactivity unprecedented among organic mixed ionic-electronic conductors (OMIECs). Using pH-dependent rotating ring-disk voltammetry, we find that this series mechanism occurs over separate potential windows on BBL. At more positive potentials, an initial reduction wave correlated with electron polaron formation in BBL produces exclusively hydro(gen) peroxide across all pH values, followed by a second, pH-dependent wave for hydro(gen) peroxide reduction at more negative potentials. At pH 14.0, this second wave enables complete four-electron reduction of O2 (n ≈ 4) to OH-, driven by formation of a bipolaronic state in BBL. Decreasing the pH instead stabilizes a hydrogenated state in BBL incapable of O-O bond cleavage, reverting selectivity to n ≈ 2. These insights reveal that the coupling between ion selectivity during electrochemical ion-insertion and product selectivity during ORR catalysis shapes active-site structure and poisoning, establishing a new design principle in the emerging field of OMIEC electrocatalysis.
中文摘要:实现无金属电极的四电子氧还原一直是一个长期挑战。本文表明,n型梯形聚合物聚苯并咪唑苯菲(BBL)通过一种电催化内层2+2串联机制突破了这一障碍,该反应模式在有机混合离子电子导体中前所未有。利用pH依赖性旋转环盘伏安法,我们发现该串联机制在BBL的不同电位窗口发生。在更正的电位下,与BBL中电子极化子形成相关的初始还原波在所有pH值下均产生氢(过)氧化物,随后在更负的电位出现第二个pH依赖性的氢(过)氧化物还原波。在pH 14.0时,该第二波驱动BBL中双极化子态的形成,实现O2到OH-的完全四电子还原(n约等于4)。降低pH值则稳定了BBL中无法断裂O-O键的氢化状态,使选择性恢复至n约等于2。这些见解表明,电化学离子插入期间的离子选择性与氧还原催化期间的产物选择性之间的耦合塑造了活性位点结构和中毒现象,确立了有机混合离子电子导体电催化这一新兴领域的新设计原则。
Consuming aquatic food products contaminated with formaldehyde (FA) and acetaldehyde (AA) can induce acute poisoning. In this study, a pre-column derivatization method using dansylhydrazine coupled with high-performance liquid chromatography-fluorescence detection was developed for the determination of FA and AA in squid and urine samples, employing an environmentally friendly polydopamine-decorated konjac glucomannan sponge (S-KGM@PDA) as a purification material. Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray photoelectron spectroscopy, and water contact angle confirmed its successful preparation. Compared with S-KGM and primary secondary amine, S-KGM@PDA exhibited higher matrix removal efficiency. The method demonstrated excellent linearity within the concentration ranges of 15-3000 ng mL-1 for FA and 44-4405 ng mL-1 for AA. Real sample analysis showed that the spiked recoveries for both FA and AA ranged from 97.2% to 109.5%, with intra-day and inter-day relative standard deviations below 8.3%. S-KGM@PDA provides a feasible option for the pretreatment of both food and biological samples.
中文摘要:食用受甲醛和乙醛污染的水产品可引发急性中毒。本研究开发了一种基于丹磺酰肼预柱衍生化结合高效液相色谱-荧光检测的方法,用于测定鱿鱼和尿液样本中的甲醛和乙醛,并采用环境友好的聚多巴胺修饰魔芋葡甘聚糖海绵作为净化材料。傅里叶变换红外光谱、扫描电子显微镜、X射线光电子能谱和水接触角分析证实了该材料的成功制备。与未修饰的海绵及伯胺相比,聚多巴胺修饰海绵表现出更高的基质去除效率。该方法在甲醛15-3000 ng/mL和乙醛44-4405 ng/mL浓度范围内显示出优异的线性关系。实际样本分析表明,两种物质的加标回收率在97.2%至109.5%之间,日内和日间相对标准偏差均低于8.3%。该材料为食品和生物样本的前处理提供了可行的选择。
7重症营养与其他 (2篇)
临床研究 (2篇)
To characterize the pediatric organ donation process and age-related differences among brain-dead donors in Japan and evaluate organ-specific transplantation rates and graft survival across age groups. Nationwide retrospective cohort study. National donor records maintained by the Japan Organ Transplant Network. All pediatric (≤ 17 yr old) brain-dead organ donors in Japan between July 17, 2010, and March 31, 2024. None. A total of 100 pediatric brain-dead organ donors were included. Donors were categorized into three age groups: younger than 6 years (n = 32), 6-14 years (n = 48), and 15-17 years (n = 20). The time intervals from hospital admission to organ procurement showed marked age-dependent prolongation, with median durations of 28, 19.5, and 13.5 days, respectively (p < 0.01). Younger donors were more frequently managed in children's hospitals and pediatric departments, whereas older donors were increasingly managed in emergency and critical care settings. Organ transplantation was achieved in 99% of donors. Organ-specific transplantation rates were consistently high for the heart, liver, and kidneys across all age groups, whereas lung and pancreas transplantation rates increased with donor age. During donor management, respiratory, cardiovascular, renal, and hepatic function were generally maintained or improved until procurement. No significant age-related differences in graft survival were observed for any organ type. The pediatric organ donation process in Japan was substantially prolonged in an age-dependent manner, particularly among donors younger than 6 years. Despite prolonged donor management, transplantation rates remained high, and no significant age-related differences in graft survival were observed. These findings highlight the importance of sustained multidisciplinary and family support throughout the donation process and may provide insights for pediatric donation systems in low-volume settings.
中文摘要:目的:描述日本脑死亡供体中儿童器官捐献流程及年龄相关差异,并评估不同年龄组的器官特异性移植率和移植物存活率。方法:全国性回顾性队列研究。数据来源为日本器官移植网络维护的国家供体记录。研究对象为2010年7月17日至2024年3月31日期间日本所有17岁及以下儿童脑死亡器官供体。结果:共纳入100名儿童脑死亡器官供体。供体按年龄分为三组:6岁以下(n=32)、6至14岁(n=48)和15至17岁(n=20)。从入院到器官获取的时间间隔显示出显著的年龄依赖性延长,中位时间分别为28天、19.5天和13.5天(p < 0.01)。年轻供体更常在儿童医院或儿科部门接受管理,而年长供体越来越多地在急诊和重症监护环境中接受管理。99%的供体实现了器官移植。所有年龄组的心脏、肝脏和肾脏移植率均持续保持高位,而肺和胰腺移植率随供体年龄增长而增加。在供体管理期间,呼吸、心血管、肾脏和肝功能通常维持或改善至获取器官时。未观察到任何器官类型的移植物存活率存在显著的年龄相关差异。结论:日本的儿童器官捐献流程呈显著的年龄依赖性延长,尤其是6岁以下供体。尽管供体管理时间延长,但移植率仍然很高,且未观察到移植物存活率的显著年龄相关差异。这些发现强调了在整个捐献过程中持续进行多学科和家庭支持的重要性,并为低容量环境下的儿童捐献系统提供了见解。
Language barriers are associated with differences in care delivery processes and outcomes in critical care settings, with differences despite language assistance services. Less is known about outcomes associated with language concordant care. Language concordance is a linguistic match between a patient's preferred language and the language used by their care team. We undertook a systematic review to examine the measurement and impact of language concordant care delivery during critical illness, inclusive of the critical care recovery period after hospitalization. A systematic review was conducted in PubMed, CINAHL, PsycINFO, Embase, and Cochrane of English-language publications from database inception to March 3, 2026. Studies that investigated adults in critical care and post-ICU recovery clinic settings that included measurement of language concordance were included. Study quality was evaluated by the Joanna Briggs Institute Critical Appraisal Checklist. Of 1,682 unique records identified, 11 were eligible for inclusion (128,181 total patients; mean [sd] age, 68.4 [17.9 yr]; 72,872 [56.9%] male and 55,082 [43.1%] female). Six studies assessed clinical decision-making. Reported outcomes included code status changes, family conferences, communication complexity, delirium, length of stay, mechanical ventilation, and mortality. Due to significant heterogeneity in study analyses and reported outcomes, data were not pooled for quantitative analysis. Current evidence suggests that language-concordant care may influence clinically meaningful processes of critical care, warranting interventional studies to guide care delivery recommendations.
中文摘要:语言障碍与重症监护环境中护理交付过程和结果的差异有关,即使存在语言辅助服务,这种差异依然存在。关于语言一致性护理相关的结果知之甚少。语言一致性是指患者的首选语言与其护理团队使用的语言之间的匹配。我们进行了一项系统评价,以考察在危重疾病期间及住院后重症监护恢复期语言一致性护理交付的测量和影响。我们在PubMed、CINAHL、PsycINFO、Embase和Cochrane数据库中检索了从数据库建立至2026年3月3日的英文出版物。纳入的研究调查了重症监护和ICU后恢复门诊环境中的成年人,并包括对语言一致性的测量。研究质量由Joanna Briggs Institute关键评估清单进行评估。在确定的1682条独特记录中,有11条符合纳入标准(共128181名患者;平均年龄68.4岁,标准差17.9年;男性72872人占56.9%,女性55082人占43.1%)。六项研究评估了临床决策。报告的结局包括抢救状态改变、家庭会议、沟通复杂性、谵妄、住院天数、机械通气和死亡率。由于研究分析和报告结局存在显著的异质性,数据未进行定量合并分析。当前证据表明,语言一致性护理可能影响重症监护中具有临床意义的过程,需要干预性研究来指导护理交付建议。
8ECMO与器官支持 (1篇)
临床研究 (1篇)
The number of centers capable of initiating extracorporeal membrane oxygenation (ECMO) for critically ill patients with refractory cardiac or respiratory failure is expanding. Historically, patients were taken to the operating room or catheterization laboratory for ECMO cannulation by cardiothoracic surgeons and perfusionists. More recently, non-surgeons who have undergone specialized training are performing percutaneous ECMO cannulation and initiation of support at the bedside at some centers. This approach is attractive, in part, because of the timely initiation of ECMO and avoidance of the risk of patient deterioration during transport to a procedural area. The purpose of this article is to provide a roadmap for intensivists and emergency physicians to lead ECMO bedside procedures including veno-venous (VV), veno-arterial (VA), and hybrid veno-arteriovenous (V-AV) cannulation at ECMO-capable centers. These procedures demand cognitive and technical skills that are already foundational to critical care practice, including vascular access guided by point-of-care ultrasound and leadership during a dynamic resuscitation. A team-based approach to bedside ECMO cannulation is presented and illustrated with figures and video, including preparation, procedural execution, subsequent patient management, and programmatic considerations such as training and credentialing requirements.
中文摘要:能够为难治性心脏或呼吸衰竭危重患者启动体外膜肺氧合(ECMO)的中心数量正在增加。历史上,患者通常被送往手术室或导管室,由心胸外科医生和灌注师进行ECMO插管。最近,一些中心接受过专门培训的 Surgeon 以外的医师在床旁进行经皮ECMO插管和支持启动。这种方法具有吸引力,部分原因在于能够及时启动ECMO并避免患者在转运至操作区域期间病情恶化。本文旨在为重症监护医师和急诊医师提供路线图,使其能够在具备ECMO能力的中心主导ECMO床旁操作,包括静脉-静脉(VV)、静脉-动脉(VA)以及混合静脉-动脉静脉(V-AV)插管。这些操作需要认知和技术技能,这些技能是重症监护实践的基础,包括基于床旁超声的血管通路引导以及在动态复苏过程中的领导力。本文通过图表和视频展示了一种基于团队的床旁ECMO插管方法,涵盖准备、程序执行、后续患者管理以及项目相关考虑因素,如培训和资质认证要求。
9心肺复苏与心脏骤停 (1篇)
基础研究 (1篇)
Patescibacteria (previously Candidate Phyla Radiation, CPR) are ultra-small bacteria with reduced genomes that often live in close association with poorly characterized microbial hosts. Their viruses, patesciphages, remain largely unexplored. Here we integrated global metagenomes and groundwater aquifer metatranscriptomics to build a resource comprising 24,523 Patescibacteria (13,242 high-quality) and 18,876 patesciphage genomes. This resource revealed a large reservoir of uncharacterized viruses: <5% of the 12,867 viral operational taxonomic units could be assigned to known viral orders, and whole-genome comparisons of unclassified Caudoviricetes identified 14 patesciphage-only clusters disconnected from ICTV references. Similar to their Patescibacteria hosts, patesciphages exhibit signatures of genome streamlining, including small genome sizes, compact coding architectures and reduced tRNA repertoires, although maintenance of anti-defence systems highlights an active evolutionary arms race. We also identified putative cross-phylum-infecting patesciphages linking Patescibacteria with phylogenetically distant prokaryotes. These findings suggest that patesciphages may act as ecological connectors and reveal previously underappreciated virus-host dynamics in ultra-small bacteria.
中文摘要:Patescibacteria(以前称为候选门辐射CPR)是基因组缩减的超小型细菌,通常与特征不明的微生物宿主密切共生。它们的病毒patesciphages在很大程度上仍未被探索。本研究整合了全球宏基因组和地下水含水层宏转录组数据,构建了一个包含24,523个Patescibacteria(其中13,242个高质量)和18,876个patesciphage基因组的资源库。该资源揭示了大量未表征的病毒:在12,867个病毒操作分类单元中,仅有不到5%可被分配至已知的病毒目,且对未分类的Caudoviricetes进行全基因组比较鉴定出14个与ICTV参考序列无关的patesciphage特有聚类。与Patescibacteria宿主相似,patesciphages表现出基因组精简的特征,包括较小的基因组大小、紧凑的编码架构和减少的tRNA库,尽管防御系统的维持突显了活跃的进化军备竞赛。我们还鉴定出潜在的跨门类感染patesciphages,将Patescibacteria与系统发育上远端的原核生物联系起来。这些发现表明patesciphages可能作为生态连接者,并揭示了超小型细菌中先前未被充分重视的病毒宿主动态。
10重症医学与其他 (1篇)
基础研究 (1篇)
To define the timing and phenotype of mitochondrial ultrastructural remodeling and electron transport chain (ETC) function in skeletal muscle during early critical illness. Secondary analysis of a prospective observational study with serial muscle biopsies. Adult ICU. Thirty-three mechanically ventilated ICU patients (median age, 49 yr; 27% women) with Sequential Organ Failure Assessment greater than or equal to 9 on three consecutive days; skeletal muscle biopsies of the vastus lateralis muscle at ICU day 5 (n = 29) and day 15 (n = 22). Healthy subjects served as controls. None. Vastus lateralis biopsies were analyzed by electron microscopy with stereology, quantitative real-time PCR (qRT-PCR), Western blotting, and spectrophotometric ETC enzyme assays (reported per tissue weight and normalized to citrate synthase [CS]). Intact mitochondrial profiles were reduced vs. controls (fold change vs. controls: day 5, 0.24 [0.18-0.34]; p = 0.039 and day 15, 0.20 [0.16-0.33]; p = 0.011) and disturbed profiles increased (day 5, 5.62 [3.20-7.17]; p < 0.001 and day 15, 5.20 [3.67-6.36]; p = 0.001), with reduced volume density of intact mitochondria (day 5, 0.33 [0.20-0.49]; p = 0.009 and day 15, 0.32 [0.21-0.50]; p = 0.005). Inner mitochondrial membrane surface-to-volume ratio was reduced at day 5 (0.69 [0.49-0.89]; p = 0.022) and remained unchanged at day 15. Complex III tissue activity was reduced at day 5 (85.6 [22.1-133.3] vs. 151.4 [100.5-205.0]; p = 0.015) and day 15 (50.5 [36.0-69.8]; p = 0.001), remaining reduced after CS normalization (day 5, 0.83 [0.34-1.49]; p = 0.040 and day 15, 0.87 [0.65-0.93]; p = 0.007). Complex IV activity remained reduced before and after CS normalization at both time points (all p < 0.001). CS activity declined by day 15 (56.3 [52.7-65.1] vs. 95.6 [80.1-133.0]; p = 0.001 and day 15 vs. day 5; p = 0.041). qRT-PCR and Western blot supported reduced ETC components and altered biogenesis signaling. Skeletal muscle mitochondrial ultrastructure is altered by ICU day 5 and remains abnormal at day 15, with persistent complex III/IV dysfunction after CS normalization. These findings define an early sustained mitochondrial remodeling phenotype in skeletal muscle during critical illness.
中文摘要:旨在明确危重疾病早期骨骼肌中线粒体超微结构重塑的时间与表型及电子传递链功能。本研究为前瞻性观察性研究的二次分析,包含系列肌肉活检。研究对象为成人ICU患者。纳入33名机械通气ICU患者(中位年龄49岁,女性占27%),连续三天序贯器官衰竭评估评分大于等于9分;于ICU第5天(n=29)和第15天(n=22)取股外侧肌进行骨骼肌活检。健康受试者作为对照。干预措施无。对股外侧肌活检样本进行电子显微镜立体定量分析、定量实时PCR、蛋白质印迹及分光光度法电子传递链酶活性测定(按组织重量报告并校正至柠檬酸合酶)。结果显示,与对照组相比,完整线粒体轮廓在第5天减少(倍数变化vs对照组:第5天0.24[0.18-0.34];p=0.039,第15天0.20[0.16-0.33];p=0.011),而受损轮廓增加(第5天5.62[3.20-7.17];p<0.001,第15天5.20[3.67-6.36];p=0.001),完整线粒体体积密度降低(第5天0.33[0.20-0.49];p=0.009,第15天0.32[0.21-0.50];p=0.005)。第5天线粒体内膜表面积与体积比降低(0.69[0.49-0.89];p=0.022),第15天保持不变。复合物III组织活性在第5天(85.6[22.1-133.3] vs 151.4[100.5-205.0];p=0.015)和第15天(50.5[36.0-69.8];p=0.001)均降低,校正至柠檬酸合酶后仍保持降低状态(第5天0.83[0.34-1.49];p=0.040,第15天0.87[0.65-0.93];p=0.007)。复合物IV活性在两个时间点校正前后均保持降低(所有p<0.001)。至第15天柠檬酸合酶活性下降(56.3[52.7-65.1] vs 95.6[80.1-133.0];p=0.001,第15天vs第5天;p=0.041)。定量实时PCR和蛋白质印迹结果支持电子传递链成分减少及生物发生信号改变。危重疾病早期至ICU第5天骨骼肌线粒体超微结构发生改变,并在第15天持续异常,校正至柠檬酸合酶后复合物III/IV功能障碍持续存在。这些发现定义了危重疾病期间骨骼肌中早期持续的线粒体重塑表型。
11其他 (1篇)
临床研究 (1篇)
End-of-life decisions are shaped by diverse biographical, social, and cultural factors. Few studies have systematically examined the impact of religion on end-of-life decisions, and even less data are available on religiosity (i.e., strength of religious faith). The Religion and religiosity in End-of-life deCisiOns in neuroCritIcaL carE (RECONCILE) study aimed to investigate whether religiosity, rather than religion, plays a decisive role in shaping end-of-life decisions. Prospective observational study. The study was conducted between 2021 and 2024 at two neuro-ICUs at Charité-Universitätsmedizin Berlin. We prospectively studied patients with acute brain injury and poor neurologic prognosis defined by the absence of regaining decision-making capacity or sufficient autonomy. A total of 100 patients were included. None. Relatives were consulted to ascertain the patients' presumed wishes regarding the continuation or withdrawal of life-sustaining intensive care. The 10-item Santa Clara Strength of Religious Faith questionnaire was applied to measure the patient´s religiosity on a scale between 10 and 40 points. We applied the t-test for independent variables to evaluate the influence of religiosity on end-of-life decisions. To adjust for possible confounders like age, sex, nationality, and religion, we calculated a logistic regression as well as an analysis of variance calculation. In patients in whom intensive care was continued, the median score was significantly higher compared with patients in whom intensive care was withdrawn (28.1 ± 9.0 vs. 20.5 ± 8.3; p < 0.001; Cohens d = 0.875). This finding was reproduced in each denominational group. Religion, age, and sex showed no significant association with the end-of-life decision behavior. Germans chose withdrawal of therapy significantly more often than non-Germans (p = 0.01) but also showed significantly lower religiosity scores (21.9 vs. 27.9; p = 0.003). The RECONCILE study demonstrates that religiosity looks more important in influencing end-of-life decisions than religion. Higher levels of religiosity were associated with a preference for more aggressive treatment, even when neurologic prognosis is poor.
中文摘要:终末期决策受多种传记、社会和文化因素影响。目前系统考察宗教对终末期决策影响的研究较少,关于宗教信仰强度(即虔诚度)的数据更为匮乏。RECONCILE研究旨在调查虔诚度而非宗教本身是否在塑造终末期决策中起决定性作用。这是一项前瞻性观察研究,于2021年至2024年间在柏林夏里特医科大学的两家神经重症监护室进行。我们前瞻性地研究了急性脑损伤且神经预后不良的患者,定义为无法恢复决策能力或足够自主性。共纳入100名患者。家属被咨询以确定患者对继续或撤除生命支持重症治疗的推定意愿。采用10项圣克拉拉宗教信仰强度问卷测量患者的虔诚度,评分范围为10至40分。应用独立样本t检验评估虔诚度对终末期决策的影响。为调整年龄、性别、国籍和宗教等可能的混杂因素,我们计算了逻辑回归以及方差分析。在继续重症治疗的患者中,中位评分显著高于撤除重症治疗的患者(28.1±9.0 vs. 20.5±8.3;p < 0.001;Cohen's d = 0.875)。这一发现在每个教派群体中均得到复现。宗教、年龄和性别与终末期决策行为无显著关联。德国人比非德国人更常选择撤除治疗(p = 0.01),但也显示出显著较低的虔诚度评分(21.9 vs. 27.9;p = 0.003)。RECONCILE研究表明,在影响终末期决策方面,虔诚度似乎比宗教更重要。较高的虔诚度水平与更积极的治疗偏好相关,即使神经预后不良。